{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:42:08Z","timestamp":1787020928200,"version":"build-2736575974"},"reference-count":410,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070459"],"award-info":[{"award-number":["82070459"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270701"],"award-info":[{"award-number":["82270701"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biosci"],"DOI":"10.1186\/s13578-025-01520-9","type":"journal-article","created":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T12:53:06Z","timestamp":1767099186000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Mechanisms, efficacy, and future perspectives of cellular-based therapies for liver fibrosis\/cirrhosis: focusing on mesenchymal stromal cells"],"prefix":"10.1186","volume":"16","author":[{"given":"Xuan","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyun","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3981-8849","authenticated-orcid":false,"given":"Bin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,30]]},"reference":[{"key":"1520_CR1","doi-asserted-by":"publisher","first-page":"671640","DOI":"10.3389\/fphar.2021.671640","volume":"12","author":"P Acharya","year":"2021","unstructured":"Acharya P, Chouhan K, Weiskirchen S, Weiskirchen R. Cellular mechanisms of liver fibrosis. Front Pharmacol. 2021;12:671640. https:\/\/doi.org\/10.3389\/fphar.2021.671640.","journal-title":"Front Pharmacol"},{"key":"1520_CR2","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/S0168-8278(02)00429-4","volume":"38","author":"SL Friedman","year":"2003","unstructured":"Friedman SL. Liver fibrosis \u2013 from bench to bedside. J Hepatol. 2003;38:38\u201353. https:\/\/doi.org\/10.1016\/S0168-8278(02)00429-4.","journal-title":"J Hepatol"},{"key":"1520_CR3","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/hep.32285","volume":"75","author":"SL Friedman","year":"2022","unstructured":"Friedman SL, Pinzani M. Hepatic fibrosis 2022: unmet needs and a blueprint for the future. Hepatology. 2022;75:473\u201388. https:\/\/doi.org\/10.1002\/hep.32285.","journal-title":"Hepatology"},{"key":"1520_CR4","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X","volume":"398","author":"P Gin\u00e8s","year":"2021","unstructured":"Gin\u00e8s P, Krag A, Abraldes JG, Sol\u00e0 E, Fabrellas N, Kamath PS. Liver cirrhosis. Lancet. 2021;398:1359\u201376. https:\/\/doi.org\/10.1016\/S0140-6736(21)01374-X.","journal-title":"Lancet"},{"key":"1520_CR5","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","volume":"14","author":"T Tsuchida","year":"2017","unstructured":"Tsuchida T, Friedman SL. Mechanisms of hepatic stellate cell activation. Nat Rev Gastroenterol Hepatol. 2017;14:397\u2013411. https:\/\/doi.org\/10.1038\/nrgastro.2017.38.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1520_CR6","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.124.002203","volume":"392","author":"S Monegatti","year":"2025","unstructured":"Monegatti S, Martinelli N, Friso S, Spronk HMH, Cate HT. Mechanisms and management of thrombosis in cancer: focus on gastrointestinal malignancies. J Pharmacol Exp Ther. 2025;392:100018. https:\/\/doi.org\/10.1124\/jpet.124.002203.","journal-title":"J Pharmacol Exp Ther"},{"key":"1520_CR7","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","volume":"18","author":"T Kisseleva","year":"2021","unstructured":"Kisseleva T, Brenner D. Molecular and cellular mechanisms of liver fibrosis and its regression. Nat Rev Gastroenterol Hepatol. 2021;18:151\u201366. https:\/\/doi.org\/10.1038\/s41575-020-00372-7.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1520_CR8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2309000","author":"SA Harrison","year":"2024","unstructured":"Harrison SA, Bedossa P, Guy CD, Schattenberg JM, Loomba R, Taub R, et al. A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis. N Engl J Med. 2024. https:\/\/doi.org\/10.1056\/NEJMoa2309000.","journal-title":"N Engl J Med"},{"key":"1520_CR9","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/s41575-023-00807-x","volume":"20","author":"L Hammerich","year":"2023","unstructured":"Hammerich L, Tacke F. Hepatic inflammatory responses in liver fibrosis. Nat Rev Gastroenterol Hepatol. 2023;20:633\u201346. https:\/\/doi.org\/10.1038\/s41575-023-00807-x.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1520_CR10","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.jhep.2013.03.033","volume":"59","author":"C Brenner","year":"2013","unstructured":"Brenner C, Galluzzi L, Kepp O, Kroemer G. Decoding cell death signals in liver inflammation. J Hepatol. 2013;59:583\u201394. https:\/\/doi.org\/10.1016\/j.jhep.2013.03.033.","journal-title":"J Hepatol"},{"key":"1520_CR11","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/BF02147594","volume":"27","author":"G Gabbiani","year":"1971","unstructured":"Gabbiani G, Ryan GB, Majno G. Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction. Experientia. 1971;27:549\u201350. https:\/\/doi.org\/10.1007\/BF02147594.","journal-title":"Experientia"},{"key":"1520_CR12","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1002\/hep.28948","volume":"65","author":"T Kisseleva","year":"2017","unstructured":"Kisseleva T. The origin of fibrogenic myofibroblasts in fibrotic liver. Hepatology. 2017;65:1039\u201343. https:\/\/doi.org\/10.1002\/hep.28948.","journal-title":"Hepatology"},{"key":"1520_CR13","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1038\/ncomms3823","volume":"4","author":"I Mederacke","year":"2013","unstructured":"Mederacke I, Hsu CC, Troeger JS, Huebener P, Mu X, Dapito DH, et al. Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology. Nat Commun. 2013;4:2823. https:\/\/doi.org\/10.1038\/ncomms3823.","journal-title":"Nat Commun"},{"key":"1520_CR14","doi-asserted-by":"publisher","first-page":"728","DOI":"10.21037\/atm-20-2948","volume":"9","author":"A Khurana","year":"2021","unstructured":"Khurana A, Sayed N, Allawadhi P, Weiskirchen R. It\u2019s all about the spaces between cells: role of extracellular matrix in liver fibrosis. Ann Transl Med. 2021;9:728. https:\/\/doi.org\/10.21037\/atm-20-2948.","journal-title":"Ann Transl Med."},{"key":"1520_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmgh.2023.09.008","author":"HY Kim","year":"2023","unstructured":"Kim HY, Sakane S, Eguileor A, Weber RCG, Lee W, Liu X, et al. The origin and fate of liver myofibroblasts. Cell Mol Gastroenterol Hepatol. 2023. https:\/\/doi.org\/10.1016\/j.jcmgh.2023.09.008.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"1520_CR16","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0955-470X(05)80009-6","volume":"7","author":"M Mito","year":"1993","unstructured":"Mito M, Kusano M, Sawa M. Hepatocyte transplantation for hepatic failure. Transplant Rev. 1993;7:35\u201343. https:\/\/doi.org\/10.1016\/S0955-470X(05)80009-6.","journal-title":"Transplant Rev"},{"key":"1520_CR17","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1634\/stemcells.2005-0542","volume":"24","author":"S Terai","year":"2006","unstructured":"Terai S, Ishikawa T, Omori K, Aoyama K, Marumoto Y, Urata Y, et al. Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy. Stem Cells. 2006;24:2292\u20138. https:\/\/doi.org\/10.1634\/stemcells.2005-0542.","journal-title":"Stem Cells"},{"key":"1520_CR18","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1634\/stemcells.2005-0629","volume":"24","author":"MY Gordon","year":"2006","unstructured":"Gordon MY, Levicar N, Pai M, Bachellier P, Dimarakis I, Al-Allaf F, et al. Characterization and clinical application of human CD34+ stem\/progenitor cell populations mobilized into the blood by granulocyte colony-stimulating factor. Stem Cells. 2006;24:1822\u201330. https:\/\/doi.org\/10.1634\/stemcells.2005-0629.","journal-title":"Stem Cells"},{"key":"1520_CR19","first-page":"459","volume":"10","author":"M Mohamadnejad","year":"2007","unstructured":"Mohamadnejad M, Alimoghaddam K, Mohyeddin-Bonab M, Bagheri M, Bashtar M, Ghanaati H, et al. Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis. Arch Iran Med. 2007;10:459\u201366.","journal-title":"Arch Iran Med"},{"key":"1520_CR20","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3727\/096368910X498241","volume":"19","author":"AA Khan","year":"2010","unstructured":"Khan AA, Shaik MV, Parveen N, Rajendraprasad A, Aleem MA, Habeeb MA, et al. Human fetal liver-derived stem cell transplantation as supportive modality in the management of end-stage decompensated liver cirrhosis. Cell Transplant. 2010;19:409\u201318. https:\/\/doi.org\/10.3727\/096368910X498241.","journal-title":"Cell Transplant"},{"key":"1520_CR21","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.trsl.2016.02.009","volume":"188","author":"D D\u2019Avola","year":"2017","unstructured":"D\u2019Avola D, Fern\u00e1ndez-Ruiz V, Carmona-Torre F, M\u00e9ndez M, P\u00e9rez-Calvo J, Pr\u00f3sper F, et al. Phase 1\u20132 pilot clinical trial in patients with decompensated liver cirrhosis treated with bone marrow\u2013derived endothelial progenitor cells. Transl Res. 2017;188:80-91.e2. https:\/\/doi.org\/10.1016\/j.trsl.2016.02.009.","journal-title":"Transl Res"},{"key":"1520_CR22","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1038\/s41591-019-0599-8","volume":"25","author":"F Moroni","year":"2019","unstructured":"Moroni F, Dwyer BJ, Graham C, Pass C, Bailey L, Ritchie L, et al. Safety profile of autologous macrophage therapy for liver cirrhosis. Nat Med. 2019;25:1560\u20135. https:\/\/doi.org\/10.1038\/s41591-019-0599-8.","journal-title":"Nat Med"},{"key":"1520_CR23","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1097\/00007890-196803000-00009","volume":"6","author":"AJ Friedenstein","year":"1968","unstructured":"Friedenstein AJ, Petrakova KV, Kurolesova AI, Frolova GP. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation. 1968;6:230\u201347. https:\/\/doi.org\/10.1097\/00007890-196803000-00009.","journal-title":"Transplantation"},{"key":"1520_CR24","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/j.1365-2184.1970.tb00347.x","volume":"3","author":"AJ Friedenstein","year":"1970","unstructured":"Friedenstein AJ, Chailakhjan RK, Lalykina KS. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Prolif. 1970;3:393\u2013403. https:\/\/doi.org\/10.1111\/j.1365-2184.1970.tb00347.x.","journal-title":"Cell Prolif"},{"key":"1520_CR25","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1002\/jor.1100090504","volume":"9","author":"AI Caplan","year":"1991","unstructured":"Caplan AI. Mesenchymal stem cells. J Orthop Res. 1991;9:641\u201350. https:\/\/doi.org\/10.1002\/jor.1100090504.","journal-title":"J Orthop Res"},{"key":"1520_CR26","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1080\/14653240500319234","volume":"7","author":"EM Horwitz","year":"2005","unstructured":"Horwitz EM, Le Blanc K, Dominici M, Mueller I, Slaper-Cortenbach I, Marini FC, et al. Clarification of the nomenclature for MSC: the International Society for Cellular Therapy position statement. Cytotherapy. 2005;7:393\u20135. https:\/\/doi.org\/10.1080\/14653240500319234.","journal-title":"Cytotherapy"},{"key":"1520_CR27","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.jcyt.2019.08.002","volume":"21","author":"S Viswanathan","year":"2019","unstructured":"Viswanathan S, Shi Y, Galipeau J, Krampera M, Leblanc K, Martin I, et al. Mesenchymal stem versus stromal cells: International Society for Cell & Gene Therapy (ISCT\u00ae) mesenchymal stromal cell committee position statement on nomenclature. Cytotherapy. 2019;21:1019\u201324. https:\/\/doi.org\/10.1016\/j.jcyt.2019.08.002.","journal-title":"Cytotherapy"},{"key":"1520_CR28","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini FC, Krause DS, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315\u20137. https:\/\/doi.org\/10.1080\/14653240600855905.","journal-title":"Cytotherapy"},{"key":"1520_CR29","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1089\/107632701300062859","volume":"7","author":"PA Zuk","year":"2001","unstructured":"Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001;7:211\u201328. https:\/\/doi.org\/10.1089\/107632701300062859.","journal-title":"Tissue Eng"},{"key":"1520_CR30","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1002\/1529-0131(200108)44:8<1928::AID-ART331>3.0.CO;2-P","volume":"44","author":"C De Bari","year":"2001","unstructured":"De Bari C, Dell\u2019Accio F, Tylzanowski P, Luyten FP. Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum. 2001;44:1928\u201342.","journal-title":"Arthritis Rheum"},{"key":"1520_CR31","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0140-6736(04)16627-0","volume":"364","author":"B-M Seo","year":"2004","unstructured":"Seo B-M, Miura M, Gronthos S, Mark Bartold P, Batouli S, Brahim J, et al. Investigation of multipotent postnatal stem cells from human periodontal ligament. Lancet. 2004;364:149\u201355. https:\/\/doi.org\/10.1016\/S0140-6736(04)16627-0.","journal-title":"Lancet"},{"key":"1520_CR32","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1182\/blood-2003-05-1670","volume":"103","author":"OK Lee","year":"2004","unstructured":"Lee OK, Kuo TK, Chen W-M, Lee K-D, Hsieh S-L, Chen T-H. Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood. 2004;103:1669\u201375. https:\/\/doi.org\/10.1182\/blood-2003-05-1670.","journal-title":"Blood"},{"key":"1520_CR33","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1634\/stemcells.2004-0058","volume":"22","author":"PS In\u2019t Anker","year":"2004","unstructured":"In\u2019t Anker PS, Scherjon SA, der Kleijburg-van Keur C, de Groot-Swings GM, Claas FH, Fibbe WE, et al. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells. 2004;22:1338\u201345. https:\/\/doi.org\/10.1634\/stemcells.2004-0058.","journal-title":"Stem Cells"},{"key":"1520_CR34","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/j.jhep.2018.01.030","volume":"68","author":"M Alfaifi","year":"2018","unstructured":"Alfaifi M, Eom YW, Newsome PN, Baik SK. Mesenchymal stromal cell therapy for liver diseases. J Hepatol. 2018;68:1272\u201385. https:\/\/doi.org\/10.1016\/j.jhep.2018.01.030.","journal-title":"J Hepatol"},{"key":"1520_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/9628536","volume":"2019","author":"B Lukomska","year":"2019","unstructured":"Lukomska B, Stanaszek L, Zuba-Surma E, Legosz P, Sarzynska S, Drela K. Challenges and controversies in human mesenchymal stem cell therapy. Stem Cells Int. 2019;2019:1\u201310. https:\/\/doi.org\/10.1155\/2019\/9628536.","journal-title":"Stem Cells Int"},{"key":"1520_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232012572","volume":"23","author":"D Zhang","year":"2022","unstructured":"Zhang D, Zhang Y, Sun B. The molecular mechanisms of liver fibrosis and its potential therapy in application. Int J Mol Sci. 2022;23:12572. https:\/\/doi.org\/10.3390\/ijms232012572.","journal-title":"Int J Mol Sci"},{"key":"1520_CR37","doi-asserted-by":"publisher","first-page":"81","DOI":"10.6002\/ect.2016.0226","volume":"16","author":"H El Baz","year":"2018","unstructured":"El Baz H, Demerdash Z, Kamel M, Atta S, Salah F, Hassan S, et al. Transplant of hepatocytes, undifferentiated mesenchymal stem cells, and in vitro hepatocyte-differentiated mesenchymal stem cells in a chronic liver failure experimental model: a comparative study. Exp Clin Transplant. 2018;16:81\u20139. https:\/\/doi.org\/10.6002\/ect.2016.0226.","journal-title":"Exp Clin Transplant"},{"key":"1520_CR38","doi-asserted-by":"publisher","first-page":"5410359","DOI":"10.1155\/2020\/5410359","volume":"2020","author":"S Hendrawan","year":"2020","unstructured":"Hendrawan S, Lheman J, Nuraeni S, Weber U, Baer HU. Hepatocyte and islet cell cotransplantation on poly-L-lactide matrix for the treatment of liver cirrhosis. Int J Hepatol. 2020;2020:5410359. https:\/\/doi.org\/10.1155\/2020\/5410359.","journal-title":"Int J Hepatol."},{"key":"1520_CR39","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.3390\/cells8111339","volume":"8","author":"D Pinheiro","year":"2019","unstructured":"Pinheiro D, Dias I, Silva KR, Stumbo AC, Thole A, Cortez E, et al. Mechanisms underlying cell therapy in liver fibrosis: an overview. Cells. 2019;8:1339. https:\/\/doi.org\/10.3390\/cells8111339.","journal-title":"Cells"},{"key":"1520_CR40","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1055\/s-0039-1688502","volume":"39","author":"PJS Lewis","year":"2019","unstructured":"Lewis PJS, Moroni F, Forbes SJ. Macrophages as a cell-based therapy for liver disease. Semin Liver Dis. 2019;39:442\u201351. https:\/\/doi.org\/10.1055\/s-0039-1688502.","journal-title":"Semin Liver Dis"},{"key":"1520_CR41","doi-asserted-by":"publisher","first-page":"564","DOI":"10.21037\/atm.2020.03.153","volume":"8","author":"Y-C Tao","year":"2020","unstructured":"Tao Y-C, Chen E-Q. Clinical application of stem cell in patients with end-stage liver disease: progress and challenges. Ann Trans Med. 2020;8:564\u2013564. https:\/\/doi.org\/10.21037\/atm.2020.03.153.","journal-title":"Ann Trans Med."},{"key":"1520_CR42","doi-asserted-by":"publisher","first-page":"15446","DOI":"10.1038\/s41598-019-51189-7","volume":"9","author":"MD Muthiah","year":"2019","unstructured":"Muthiah MD, Huang DQ, Zhou L, Jumat NH, Choolani M, Chan JKY, et al. A murine model demonstrating reversal of structural and functional correlates of cirrhosis with progenitor cell transplantation. Sci Rep. 2019;9:15446. https:\/\/doi.org\/10.1038\/s41598-019-51189-7.","journal-title":"Sci Rep"},{"key":"1520_CR43","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/labinvest.2011.143","volume":"92","author":"M-N Chobert","year":"2012","unstructured":"Chobert M-N, Couchie D, Fourcot A, Zafrani E-S, Laperche Y, Mavier P, et al. Liver precursor cells increase hepatic fibrosis induced by chronic carbon tetrachloride intoxication in rats. Lab Invest. 2012;92:135\u201350. https:\/\/doi.org\/10.1038\/labinvest.2011.143.","journal-title":"Lab Invest"},{"key":"1520_CR44","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1080\/15384101.2017.1325976","volume":"16","author":"X Pan","year":"2017","unstructured":"Pan X, Jing Y, Liu W, Han Z, Li R, Yang Y, et al. Lipopolysaccharide induces the differentiation of hepatic progenitor cells into myofibroblasts via activation of the hedgehog signaling pathway. Cell Cycle. 2017;16:1357\u201365. https:\/\/doi.org\/10.1080\/15384101.2017.1325976.","journal-title":"Cell Cycle"},{"key":"1520_CR45","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41418-019-0340-7","volume":"27","author":"W Liu","year":"2020","unstructured":"Liu W, Jing Y, Gao L, Li R, Yang X, Pan X, et al. Lipopolysaccharide induces the differentiation of hepatic progenitor cells into myofibroblasts constitutes the hepatocarcinogenesis-associated microenvironment. Cell Death Differ. 2020;27:85\u2013101. https:\/\/doi.org\/10.1038\/s41418-019-0340-7.","journal-title":"Cell Death Differ"},{"key":"1520_CR46","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/stem.2710","volume":"36","author":"A Irudayaswamy","year":"2018","unstructured":"Irudayaswamy A, Muthiah M, Zhou L, Hung H, Jumat NHB, Haque J, et al. Long-term fate of human fetal liver progenitor cells transplanted in injured mouse livers. Stem Cells. 2018;36:103\u201313. https:\/\/doi.org\/10.1002\/stem.2710.","journal-title":"Stem Cells"},{"key":"1520_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0187970","volume":"12","author":"D Pinheiro","year":"2017","unstructured":"Pinheiro D, Leir\u00f3s L, D\u00e1u JBT, Stumbo AC, Thole AA, Cortez EAC, et al. Cytokines, hepatic cell profiling and cell interactions during bone marrow cell therapy for liver fibrosis in cholestatic mice. PLoS ONE. 2017;12:e0187970. https:\/\/doi.org\/10.1371\/journal.pone.0187970.","journal-title":"PLoS ONE"},{"key":"1520_CR48","doi-asserted-by":"publisher","first-page":"268","DOI":"10.22074\/cellj.2019.6108","volume":"21","author":"A Esmaeilzadeh","year":"2019","unstructured":"Esmaeilzadeh A, Ommati H, Kooshyar MM, Jarahi L, Akhavan Rezayat K, Saberi S, et al. Autologous bone marrow stem cell transplantation in liver cirrhosis after correcting nutritional anomalies, a controlled clinical study. Cell J (Yakhteh). 2019;21:268\u201373. https:\/\/doi.org\/10.22074\/cellj.2019.6108.","journal-title":"Cell J (Yakhteh)."},{"key":"1520_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-022-02762-x","volume":"13","author":"TL Nguyen","year":"2022","unstructured":"Nguyen TL, Nguyen HP, Ngo DM, Ha THT, Mai K-A, Bui TH, et al. Autologous bone marrow mononuclear cell infusion for liver cirrhosis after the Kasai operation in children with biliary atresia. Stem Cell Res Ther. 2022;13:108. https:\/\/doi.org\/10.1186\/s13287-022-02762-x.","journal-title":"Stem Cell Res Ther"},{"key":"1520_CR50","doi-asserted-by":"publisher","first-page":"87","DOI":"10.5966\/sctm.2015-0004","volume":"5","author":"M Mohamadnejad","year":"2016","unstructured":"Mohamadnejad M, Vosough M, Moossavi S, Nikfam S, Mardpour S, Akhlaghpoor S, et al. Intraportal infusion of bone marrow mononuclear or CD133+ cells in patients with decompensated cirrhosis: a double-blind randomized controlled trial. Stem Cells Transl Med. 2016;5:87\u201394. https:\/\/doi.org\/10.5966\/sctm.2015-0004.","journal-title":"Stem Cells Transl Med"},{"key":"1520_CR51","first-page":"12","volume":"14","author":"S Nikeghbalian","year":"2011","unstructured":"Nikeghbalian S, Pournasr B, Aghdami N, Rasekhi A, Geramizadeh B, Hosseini Asl SMK, et al. Autologous transplantation of bone marrow-derived mononuclear and CD133(+) cells in patients with decompensated cirrhosis. Arch Iran Med. 2011;14:12\u20137.","journal-title":"Arch Iran Med"},{"key":"1520_CR52","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3904\/kjim.2015.267","volume":"32","author":"SJ Yu","year":"2017","unstructured":"Yu SJ, Yoon J-H, Kim W, Lee JM, Lee YB, Cho Y, et al. Ultrasound-guided percutaneous portal transplantation of peripheral blood monocytes in patients with liver cirrhosis. Korean J Intern Med. 2017;32:261\u20138. https:\/\/doi.org\/10.3904\/kjim.2015.267.","journal-title":"Korean J Intern Med"},{"key":"1520_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0053719","volume":"8","author":"L Spahr","year":"2013","unstructured":"Spahr L, Chalandon Y, Terraz S, Kindler V, Rubbia-Brandt L, Frossard J-L, et al. Autologous bone marrow mononuclear cell transplantation in patients with decompensated alcoholic liver disease: a randomized controlled trial. PLoS ONE. 2013;8:e53719. https:\/\/doi.org\/10.1371\/journal.pone.0053719.","journal-title":"PLoS ONE"},{"key":"1520_CR54","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jhep.2020.09.014","volume":"74","author":"BJ Dwyer","year":"2021","unstructured":"Dwyer BJ, Macmillan MT, Brennan PN, Forbes SJ. Cell therapy for advanced liver diseases: repair or rebuild. J Hepatol. 2021;74:185\u201399. https:\/\/doi.org\/10.1016\/j.jhep.2020.09.014.","journal-title":"J Hepatol"},{"key":"1520_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15283\/ijsc19127","volume":"13","author":"JY Lee","year":"2019","unstructured":"Lee JY, Hong S-H. Hematopoietic stem cells and their roles in tissue regeneration. Int J Stem Cells. 2019;13:1\u201312. https:\/\/doi.org\/10.15283\/ijsc19127.","journal-title":"Int J Stem Cells"},{"key":"1520_CR56","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1136\/mp.56.2.86","volume":"56","author":"SL Preston","year":"2003","unstructured":"Preston SL. The new stem cell biology: something for everyone. J Mol Pathol. 2003;56:86\u201396. https:\/\/doi.org\/10.1136\/mp.56.2.86.","journal-title":"J Mol Pathol"},{"key":"1520_CR57","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1038\/81326","volume":"6","author":"E Lagasse","year":"2000","unstructured":"Lagasse E, Connors H, Al-Dhalimy M, Reitsma M, Dohse M, Osborne L, et al. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med. 2000;6:1229\u201334. https:\/\/doi.org\/10.1038\/81326.","journal-title":"Nat Med"},{"key":"1520_CR58","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1634\/stemcells.2004-0283","volume":"23","author":"JS Am Esch","year":"2005","unstructured":"Am Esch JS, Knoefel WT, Klein M, Ghodsizad A, Fuerst G, Poll LW, et al. Portal application of autologous CD133 + bone marrow cells to the liver: a novel concept to support hepatic regeneration. Stem Cells. 2005;23:463\u201370. https:\/\/doi.org\/10.1634\/stemcells.2004-0283.","journal-title":"Stem Cells"},{"key":"1520_CR59","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.exphem.2004.09.005","volume":"33","author":"E Yannaki","year":"2005","unstructured":"Yannaki E, Athanasiou E, Xagorari A, Constantinou V, Batsis I, Kaloyannidis P, et al. G-CSF\u2013primed hematopoietic stem cells or G-CSF per se accelerate recovery and improve survival after liver injury, predominantly by promoting endogenous repair programs. Exp Hematol. 2005;33:108\u201319. https:\/\/doi.org\/10.1016\/j.exphem.2004.09.005.","journal-title":"Exp Hematol"},{"key":"1520_CR60","doi-asserted-by":"publisher","DOI":"10.5812\/hepatmon.32498","author":"Q Deng","year":"2015","unstructured":"Deng Q, Cai T, Zhang S, Hu A, Zhang X, Wang Y, et al. Autologous peripheral blood stem cell transplantation improves portal hemodynamics in patients with hepatitis B virus-related decompensated cirrhosis. Hepat Mon. 2015. https:\/\/doi.org\/10.5812\/hepatmon.32498.","journal-title":"Hepat Mon"},{"key":"1520_CR61","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v13.i24.3359","volume":"13","author":"M Mohamadnejad","year":"2007","unstructured":"Mohamadnejad M. Phase 1 human trial of autologous bone marrow-hematopoietic stem cell transplantation in patients with decompensated cirrhosis. WJG. 2007;13:3359. https:\/\/doi.org\/10.3748\/wjg.v13.i24.3359.","journal-title":"WJG"},{"key":"1520_CR62","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S2468-1253(17)30326-6","volume":"3","author":"PN Newsome","year":"2018","unstructured":"Newsome PN, Fox R, King AL, Barton D, Than N-N, Moore J, et al. Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trial. Lancet Gastroenterol Hepatol. 2018;3:25\u201336. https:\/\/doi.org\/10.1016\/S2468-1253(17)30326-6.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"1520_CR63","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1053\/j.gastro.2011.11.027","volume":"142","author":"V Garg","year":"2012","unstructured":"Garg V, Garg H, Khan A, Trehanpati N, Kumar A, Sharma BC, et al. Granulocyte colony-stimulating factor mobilizes CD34(+) cells and improves survival of patients with acute-on-chronic liver failure. Gastroenterology. 2012;142:505-512.e1. https:\/\/doi.org\/10.1053\/j.gastro.2011.11.027.","journal-title":"Gastroenterology"},{"key":"1520_CR64","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.cgh.2020.02.022","volume":"19","author":"A De","year":"2021","unstructured":"De A, Kumari S, Singh A, Kaur A, Sharma R, Bhalla A, et al. Multiple cycles of granulocyte colony-stimulating factor increase survival times of patients with decompensated cirrhosis in a randomized trial. Clin Gastroenterol Hepatol. 2021;19:375-383.e5. https:\/\/doi.org\/10.1016\/j.cgh.2020.02.022.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1520_CR65","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1007\/s12072-022-10314-x","volume":"16","author":"A Venkitaraman","year":"2022","unstructured":"Venkitaraman A, De A, Verma N, Kumari S, Leishangthem B, Sharma RR, et al. Multiple cycles of granulocyte colony-stimulating factor in decompensated cirrhosis: a double-blind RCT. Hepatol Int. 2022;16:1127. https:\/\/doi.org\/10.1007\/s12072-022-10314-x.","journal-title":"Hepatol Int"},{"key":"1520_CR66","first-page":"794","volume":"88","author":"M Picardi","year":"2003","unstructured":"Picardi M, De Rosa G, Selleri C, Scarpato N, Soscia E, Martinelli V, et al. Spleen enlargement following recombinant human granulocyte colony-stimulating factor administration for peripheral blood stem cell mobilization. Haematologica. 2003;88:794\u2013800.","journal-title":"Haematologica"},{"key":"1520_CR67","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1016\/j.exphem.2006.06.012","volume":"34","author":"E Yannaki","year":"2006","unstructured":"Yannaki E, Anagnostopoulos A, Kapetanos D, Xagorari A, Iordanidis F, Batsis I, et al. Lasting amelioration in the clinical course of decompensated alcoholic cirrhosis with boost infusions of mobilized peripheral blood stem cells. Exp Hematol. 2006;34:1583. https:\/\/doi.org\/10.1016\/j.exphem.2006.06.012.","journal-title":"Exp Hematol"},{"key":"1520_CR68","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1126\/science.275.5302.964","volume":"275","author":"T Asahara","year":"1997","unstructured":"Asahara T, Murohara T, Sullivan A, Silver M, Van Der Zee R, Li T, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997;275:964\u20136. https:\/\/doi.org\/10.1126\/science.275.5302.964.","journal-title":"Science"},{"key":"1520_CR69","doi-asserted-by":"publisher","first-page":"354","DOI":"10.3389\/fmed.2018.00354","volume":"5","author":"C Keighron","year":"2018","unstructured":"Keighron C, Lyons CJ, Creane M, O\u2019Brien T, Liew A. Recent advances in endothelial progenitor cells toward their use in clinical translation. Front Med (Lausanne). 2018;5:354. https:\/\/doi.org\/10.3389\/fmed.2018.00354.","journal-title":"Front Med (Lausanne)"},{"key":"1520_CR70","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1002\/sctm.16-0360","volume":"6","author":"RJ Medina","year":"2017","unstructured":"Medina RJ, Barber CL, Sabatier F, Dignat-George F, Melero-Martin JM, Khosrotehrani K, et al. Endothelial progenitors: a consensus statement on nomenclature. Stem Cells Transl Med. 2017;6:1316\u201320. https:\/\/doi.org\/10.1002\/sctm.16-0360.","journal-title":"Stem Cells Transl Med"},{"key":"1520_CR71","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1002\/lt.21845","volume":"15","author":"F Liu","year":"2009","unstructured":"Liu F, Liu Z-D, Wu N, Cong X, Fei R, Chen H-S, et al. Transplanted endothelial progenitor cells ameliorate carbon tetrachloride-induced liver cirrhosis in rats. Liver Transpl. 2009;15:1092. https:\/\/doi.org\/10.1002\/lt.21845.","journal-title":"Liver Transpl"},{"key":"1520_CR72","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1111\/j.1365-2362.2011.02637.x","volume":"42","author":"T Nakamura","year":"2012","unstructured":"Nakamura T, Torimura T, Iwamoto H, Masuda H, Naitou M, Koga H, et al. Prevention of liver fibrosis and liver reconstitution of DMN\u2010treated rat liver by transplanted EPCs. Eur J Clin Invest. 2012;42:717. https:\/\/doi.org\/10.1111\/j.1365-2362.2011.02637.x.","journal-title":"Eur J Clin Invest"},{"key":"1520_CR73","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1053\/j.gastro.2007.03.110","volume":"133","author":"T Nakamura","year":"2007","unstructured":"Nakamura T, Torimura T, Sakamoto M, Hashimoto O, Taniguchi E, Inoue K, et al. Significance and therapeutic potential of endothelial progenitor cell transplantation in a cirrhotic liver rat model. Gastroenterology. 2007;133:91-107.e1. https:\/\/doi.org\/10.1053\/j.gastro.2007.03.110.","journal-title":"Gastroenterology"},{"key":"1520_CR74","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/j.1440-1746.2012.07238.x","volume":"28","author":"M Sakamoto","year":"2013","unstructured":"Sakamoto M, Nakamura T, Torimura T, Iwamoto H, Masuda H, Koga H, et al. Transplantation of endothelial progenitor cells ameliorates vascular dysfunction and portal hypertension in carbon tetrachloride\u2010induced rat liver cirrhotic model. J Gastroenterol Hepatol. 2013;28:168\u201378. https:\/\/doi.org\/10.1111\/j.1440-1746.2012.07238.x.","journal-title":"J Gastroenterol Hepatol"},{"key":"1520_CR75","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23126649","volume":"23","author":"E Binatti","year":"2022","unstructured":"Binatti E, Gerussi A, Barisani D, Invernizzi P. The role of macrophages in liver fibrosis: new therapeutic opportunities. Int J Mol Sci. 2022;23:6649. https:\/\/doi.org\/10.3390\/ijms23126649.","journal-title":"Int J Mol Sci"},{"key":"1520_CR76","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1186\/s13287-018-1039-2","volume":"9","author":"D Philipp","year":"2018","unstructured":"Philipp D, Suhr L, Wahlers T, Choi Y-H, Paunel-G\u00f6rg\u00fcl\u00fc A. Preconditioning of bone marrow-derived mesenchymal stem cells highly strengthens their potential to promote IL-6-dependent M2b polarization. Stem Cell Res Ther. 2018;9:286. https:\/\/doi.org\/10.1186\/s13287-018-1039-2.","journal-title":"Stem Cell Res Ther"},{"key":"1520_CR77","doi-asserted-by":"publisher","DOI":"10.12703\/P6-13","author":"FO Martinez","year":"2014","unstructured":"Martinez FO, Gordon S. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep. 2014. https:\/\/doi.org\/10.12703\/P6-13.","journal-title":"F1000Prime Rep."},{"key":"1520_CR78","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.iliver.2022.11.002","volume":"1","author":"L Deng","year":"2022","unstructured":"Deng L, Wu B, Liang K, Liao H, Du Y. Precise cell therapy for liver fibrosis: endothelial cell and macrophage therapy. iLIVER. 2022;1:265\u201374. https:\/\/doi.org\/10.1016\/j.iliver.2022.11.002.","journal-title":"iLIVER"},{"key":"1520_CR79","doi-asserted-by":"publisher","first-page":"1265935","DOI":"10.3389\/fphar.2023.1265935","volume":"14","author":"D Ping","year":"2023","unstructured":"Ping D, Peng Y, Hu X, Liu C. Macrophage cytotherapy on liver cirrhosis. Front Pharmacol. 2023;14:1265935. https:\/\/doi.org\/10.3389\/fphar.2023.1265935.","journal-title":"Front Pharmacol"},{"key":"1520_CR80","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1119964109","author":"P Ramachandran","year":"2012","unstructured":"Ramachandran P, Pellicoro A, Vernon MA, Boulter L, Aucott RL, Ali A, et al. Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis. Proc Natl Acad Sci USA. 2012. https:\/\/doi.org\/10.1073\/pnas.1119964109.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1520_CR81","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1002\/hep.24315","volume":"53","author":"JA Thomas","year":"2011","unstructured":"Thomas JA, Pope C, Wojtacha D, Robson AJ, Gordon\u2010Walker TT, Hartland S, et al. Macrophage therapy for murine liver fibrosis recruits host effector cells improving fibrosis, regeneration, and function. Hepatology. 2011;53:2003\u201315. https:\/\/doi.org\/10.1002\/hep.24315.","journal-title":"Hepatology"},{"key":"1520_CR82","doi-asserted-by":"publisher","DOI":"10.1177\/09636897211004090","volume":"30","author":"W Li","year":"2021","unstructured":"Li W, He F. Infusion of Kupffer cells expanded in vitro ameliorated liver fibrosis in a murine model of liver injury. Cell Transplant. 2021;30:9636897211004090. https:\/\/doi.org\/10.1177\/09636897211004090.","journal-title":"Cell Transplant"},{"key":"1520_CR83","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-053190","volume":"11","author":"PN Brennan","year":"2021","unstructured":"Brennan PN, MacMillan M, Manship T, Moroni F, Glover A, Graham C, et al. Study protocol: a multicentre, open-label, parallel-group, phase 2, randomised controlled trial of autologous macrophage therapy for liver cirrhosis (MATCH). BMJ Open. 2021;11:e053190. https:\/\/doi.org\/10.1136\/bmjopen-2021-053190.","journal-title":"BMJ Open"},{"key":"1520_CR84","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2012.00297","author":"E Eggenhofer","year":"2012","unstructured":"Eggenhofer E, Benseler V, Kroemer A, Popp FC, Geissler EK, Schlitt HJ, et al. Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion. Front Immun. 2012. https:\/\/doi.org\/10.3389\/fimmu.2012.00297.","journal-title":"Front Immun"},{"key":"1520_CR85","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/sctm.18-0105","volume":"8","author":"Y Watanabe","year":"2019","unstructured":"Watanabe Y, Tsuchiya A, Seino S, Kawata Y, Kojima Y, Ikarashi S, et al. Mesenchymal stem cells and induced bone marrow-derived macrophages synergistically improve liver fibrosis in mice. Stem Cells Transl Med. 2019;8:271\u201384. https:\/\/doi.org\/10.1002\/sctm.18-0105.","journal-title":"Stem Cells Transl Med"},{"key":"1520_CR86","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.650664","author":"D Garc\u00eda-Bernal","year":"2021","unstructured":"Garc\u00eda-Bernal D, Garc\u00eda-Arranz M, Y\u00e1\u00f1ez RM, Herv\u00e1s-Salcedo R, Cort\u00e9s A, Fern\u00e1ndez-Garc\u00eda M, et al. The current status of mesenchymal stromal cells: controversies, unresolved issues and some promising solutions to improve their therapeutic efficacy. Front Cell Dev Biol. 2021. https:\/\/doi.org\/10.3389\/fcell.2021.650664.","journal-title":"Front Cell Dev Biol."},{"key":"1520_CR87","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s13287-022-02858-4","volume":"13","author":"M Yuan","year":"2022","unstructured":"Yuan M, Hu X, Yao L, Jiang Y, Li L. Mesenchymal stem cell homing to improve therapeutic efficacy in liver disease. Stem Cell Res Ther. 2022;13:179. https:\/\/doi.org\/10.1186\/s13287-022-02858-4.","journal-title":"Stem Cell Res Ther"},{"key":"1520_CR88","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1002\/hep.20469","volume":"40","author":"K-D Lee","year":"2004","unstructured":"Lee K-D, Kuo TK-C, Whang-Peng J, Chung Y-F, Lin C-T, Chou S-H, et al. In vitro hepatic differentiation of human mesenchymal stem cells. Hepatology. 2004;40:1275\u201384. https:\/\/doi.org\/10.1002\/hep.20469.","journal-title":"Hepatology"},{"key":"1520_CR89","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1053\/jhep.2000.9124","volume":"32","author":"ND Theise","year":"2000","unstructured":"Theise ND, Nimmakayalu M, Gardner R, Illei PB, Morgan G, Teperman L, et al. Liver from bone marrow in humans. Hepatology. 2000;32:11\u20136. https:\/\/doi.org\/10.1053\/jhep.2000.9124.","journal-title":"Hepatology"},{"key":"1520_CR90","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/hep.21704","volume":"46","author":"A Banas","year":"2007","unstructured":"Banas A, Teratani T, Yamamoto Y, Tokuhara M, Takeshita F, Quinn G, et al. Adipose tissue-derived mesenchymal stem cells as a source of human hepatocytes. Hepatology. 2007;46:219\u201328. https:\/\/doi.org\/10.1002\/hep.21704.","journal-title":"Hepatology"},{"key":"1520_CR91","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/j.bbrc.2005.03.086","volume":"330","author":"SH Hong","year":"2005","unstructured":"Hong SH, Gang EJ, Jeong JA, Ahn C, Hwang SH, Yang IH, et al. In vitro differentiation of human umbilical cord blood-derived mesenchymal stem cells into hepatocyte-like cells. Biochem Biophys Res Commun. 2005;330:1153\u201361. https:\/\/doi.org\/10.1016\/j.bbrc.2005.03.086.","journal-title":"Biochem Biophys Res Commun"},{"key":"1520_CR92","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.bbrc.2004.12.158","volume":"328","author":"MJ Seo","year":"2005","unstructured":"Seo MJ, Suh SY, Bae YC, Jung JS. Differentiation of human adipose stromal cells into hepatic lineage in vitro and in vivo. Biochem Biophys Res Commun. 2005;328:258\u201364. https:\/\/doi.org\/10.1016\/j.bbrc.2004.12.158.","journal-title":"Biochem Biophys Res Commun"},{"key":"1520_CR93","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1182\/blood-2005-02-0572","volume":"106","author":"Y Sato","year":"2005","unstructured":"Sato Y, Araki H, Kato J, Nakamura K, Kawano Y, Kobune M, et al. Human mesenchymal stem cells xenografted directly to rat liver are differentiated into human hepatocytes without fusion. Blood. 2005;106:756\u201363. https:\/\/doi.org\/10.1182\/blood-2005-02-0572.","journal-title":"Blood"},{"key":"1520_CR94","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1136\/gut.2005.090050","volume":"56","author":"I Aurich","year":"2007","unstructured":"Aurich I, Mueller LP, Aurich H, Luetzkendorf J, Tisljar K, Dollinger MM, et al. Functional integration of hepatocytes derived from human mesenchymal stem cells into mouse livers. Gut. 2007;56:405\u201315. https:\/\/doi.org\/10.1136\/gut.2005.090050.","journal-title":"Gut"},{"key":"1520_CR95","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.stem.2014.11.004","volume":"16","author":"R Kramann","year":"2015","unstructured":"Kramann R, Schneider RK, DiRocco DP, Machado F, Fleig S, Bondzie PA, et al. Perivascular Gli1+ progenitors are key contributors to injury-induced organ fibrosis. Cell Stem Cell. 2015;16:51\u201366. https:\/\/doi.org\/10.1016\/j.stem.2014.11.004.","journal-title":"Cell Stem Cell"},{"key":"1520_CR96","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s00423-016-1380-9","volume":"401","author":"G Adas","year":"2016","unstructured":"Adas G, Koc B, Adas M, Duruksu G, Subasi C, Kemik O, et al. Effects of mesenchymal stem cells and VEGF on liver regeneration following major resection. Langenbecks Arch Surg. 2016;401:725\u201340. https:\/\/doi.org\/10.1007\/s00423-016-1380-9.","journal-title":"Langenbecks Arch Surg"},{"key":"1520_CR97","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1089\/scd.2011.0560","volume":"21","author":"SMG Fouraschen","year":"2012","unstructured":"Fouraschen SMG, Pan Q, De Ruiter PE, Farid WRR, Kazemier G, Kwekkeboom J, et al. Secreted factors of human liver-derived mesenchymal stem cells promote liver regeneration early after partial hepatectomy. Stem Cells Dev. 2012;21:2410\u20139. https:\/\/doi.org\/10.1089\/scd.2011.0560.","journal-title":"Stem Cells Dev"},{"key":"1520_CR98","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242015212","volume":"24","author":"IV Kholodenko","year":"2023","unstructured":"Kholodenko IV, Kholodenko RV, Yarygin KN. The crosstalk between mesenchymal stromal\/stem cells and hepatocytes in homeostasis and under stress. Int J Mol Sci. 2023;24:15212. https:\/\/doi.org\/10.3390\/ijms242015212.","journal-title":"Int J Mol Sci"},{"key":"1520_CR99","doi-asserted-by":"publisher","first-page":"12204","DOI":"10.7150\/thno.47683","volume":"10","author":"J Xu","year":"2020","unstructured":"Xu J, Wang X, Chen J, Chen S, Li Z, Liu H, et al. Embryonic stem cell-derived mesenchymal stem cells promote colon epithelial integrity and regeneration by elevating circulating IGF-1 in colitis mice. Theranostics. 2020;10:12204\u201322. https:\/\/doi.org\/10.7150\/thno.47683.","journal-title":"Theranostics"},{"key":"1520_CR100","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1186\/s13287-022-03030-8","volume":"13","author":"Q Zhou","year":"2022","unstructured":"Zhou Q, Rong C, Gu T, Li H, Wu L, Zhuansun X, et al. Mesenchymal stem cells improve liver fibrosis and protect hepatocytes by promoting microRNA-148a-5p-mediated inhibition of Notch signaling pathway. Stem Cell Res Ther. 2022;13:354. https:\/\/doi.org\/10.1186\/s13287-022-03030-8.","journal-title":"Stem Cell Res Ther"},{"key":"1520_CR101","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1002\/hep.22236","volume":"47","author":"D Van Poll","year":"2008","unstructured":"Van Poll D, Parekkadan B, Cho CH, Berthiaume F, Nahmias Y, Tilles AW, et al. Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo. Hepatology. 2008;47:1634\u201343. https:\/\/doi.org\/10.1002\/hep.22236.","journal-title":"Hepatology"},{"key":"1520_CR102","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04708-w","volume":"13","author":"F Lin","year":"2022","unstructured":"Lin F, Chen W, Zhou J, Zhu J, Yao Q, Feng B, et al. Mesenchymal stem cells protect against ferroptosis via exosome-mediated stabilization of SLC7A11 in acute liver injury. Cell Death Dis. 2022;13:271. https:\/\/doi.org\/10.1038\/s41419-022-04708-w.","journal-title":"Cell Death Dis"},{"key":"1520_CR103","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.860225","volume":"13","author":"P Chen","year":"2022","unstructured":"Chen P, Zhou Y, Han C, Chen L, Wang Y, Zhuang Z, et al. Stem cells from human exfoliated deciduous teeth alleviate liver cirrhosis via inhibition of Gasdermin D-executed hepatocyte pyroptosis. Front Immunol. 2022;13:860225. https:\/\/doi.org\/10.3389\/fimmu.2022.860225.","journal-title":"Front Immunol"},{"key":"1520_CR104","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05303-9","volume":"13","author":"D Lin","year":"2022","unstructured":"Lin D, Chen H, Xiong J, Zhang J, Hu Z, Gao J, et al. Mesenchymal stem cells exosomal let-7a-5p improve autophagic flux and alleviate liver injury in acute-on-chronic liver failure by promoting nuclear expression of TFEB. Cell Death Dis. 2022;13:865. https:\/\/doi.org\/10.1038\/s41419-022-05303-9.","journal-title":"Cell Death Dis"},{"key":"1520_CR105","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110497","volume":"121","author":"H Tao","year":"2023","unstructured":"Tao H, Liu Q, Zeng A, Song L. Unlocking the potential of mesenchymal stem cells in liver fibrosis: insights into the impact of autophagy and aging. Int Immunopharmacol. 2023;121:110497. https:\/\/doi.org\/10.1016\/j.intimp.2023.110497.","journal-title":"Int Immunopharmacol"},{"key":"1520_CR106","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1002\/sctm.19-0446","volume":"9","author":"R Stavely","year":"2020","unstructured":"Stavely R, Nurgali K. The emerging antioxidant paradigm of mesenchymal stem cell therapy. Stem Cells Transl Med. 2020;9:985\u20131006. https:\/\/doi.org\/10.1002\/sctm.19-0446.","journal-title":"Stem Cells Transl Med"},{"key":"1520_CR107","doi-asserted-by":"publisher","first-page":"E206","DOI":"10.1111\/hepr.12204","volume":"44","author":"LF Quintanilha","year":"2014","unstructured":"Quintanilha LF, Takami T, Hirose Y, Fujisawa K, Murata Y, Yamamoto N, et al. Canine mesenchymal stem cells show antioxidant properties against thioacetamide-induced liver injury in vitro and in vivo: Antioxidant activity of mesenchymal cells in liver. Hepatol Res. 2014;44:E206\u201317. https:\/\/doi.org\/10.1111\/hepr.12204.","journal-title":"Hepatol Res"},{"key":"1520_CR108","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116133","volume":"171","author":"P Chen","year":"2024","unstructured":"Chen P, Yuan M, Yao L, Xiong Z, Liu P, Wang Z, et al. Human umbilical cord-derived mesenchymal stem cells ameliorate liver fibrosis by improving mitochondrial function via Slc25a47-Sirt3 signaling pathway. Biomed Pharmacother. 2024;171:116133. https:\/\/doi.org\/10.1016\/j.biopha.2024.116133.","journal-title":"Biomed Pharmacother"},{"key":"1520_CR109","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1186\/s13287-022-03041-5","volume":"13","author":"P Liu","year":"2022","unstructured":"Liu P, Mao Y, Xie Y, Wei J, Yao J. Stem cells for treatment of liver fibrosis\/cirrhosis: clinical progress and therapeutic potential. Stem Cell Res Ther. 2022;13:356. https:\/\/doi.org\/10.1186\/s13287-022-03041-5.","journal-title":"Stem Cell Res Ther"},{"key":"1520_CR110","doi-asserted-by":"publisher","first-page":"61","DOI":"10.18632\/aging.202348","volume":"13","author":"J Na","year":"2020","unstructured":"Na J, Song J, Kim HH, Seok J, Kim JY, Jun JH, et al. Human placenta-derived mesenchymal stem cells trigger repair system in TAA-injured rat model via antioxidant effect. Aging. 2020;13:61\u201376. https:\/\/doi.org\/10.18632\/aging.202348.","journal-title":"Aging"},{"key":"1520_CR111","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/1239143","volume":"2018","author":"H Qiao","year":"2018","unstructured":"Qiao H, Zhou Y, Qin X, Cheng J, He Y, Jiang Y. NADPH oxidase signaling pathway mediates mesenchymal stem cell-induced inhibition of hepatic stellate cell activation. Stem Cells Int. 2018;2018:1\u201313. https:\/\/doi.org\/10.1155\/2018\/1239143.","journal-title":"Stem Cells Int"},{"key":"1520_CR112","doi-asserted-by":"publisher","first-page":"661","DOI":"10.3389\/fphys.2018.00661","volume":"9","author":"MI Guill\u00e9n","year":"2018","unstructured":"Guill\u00e9n MI, Platas J, P\u00e9rez Del Caz MD, Mirabet V, Alcaraz MJ. Paracrine anti-inflammatory effects of adipose tissue-derived mesenchymal stem cells in human monocytes. Front Physiol. 2018;9:661. https:\/\/doi.org\/10.3389\/fphys.2018.00661.","journal-title":"Front Physiol"},{"key":"1520_CR113","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1002\/stem.2417","volume":"34","author":"D Jiang","year":"2016","unstructured":"Jiang D, Muschhammer J, Qi Y, K\u00fcgler A, de Vries JC, Saffarzadeh M, et al. Suppression of neutrophil-mediated tissue damage-a novel skill of mesenchymal stem cells. Stem Cells. 2016;34:2393\u2013406. https:\/\/doi.org\/10.1002\/stem.2417.","journal-title":"Stem Cells"},{"key":"1520_CR114","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1002\/stem.1608","volume":"32","author":"JY Oh","year":"2014","unstructured":"Oh JY, Ko JH, Lee HJ, Yu JM, Choi H, Kim MK, et al. Mesenchymal stem\/stromal cells inhibit the NLRP3 inflammasome by decreasing mitochondrial reactive oxygen species. Stem Cells. 2014;32:1553\u201363. https:\/\/doi.org\/10.1002\/stem.1608.","journal-title":"Stem Cells"},{"key":"1520_CR115","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1248\/bpb.b16-00777","volume":"40","author":"W Yan","year":"2017","unstructured":"Yan W, Li D, Chen T, Tian G, Zhou P, Ju X. Umbilical cord MSCs reverse D-galactose-induced hepatic mitochondrial dysfunction via activation of Nrf2\/HO-1 pathway. Biol Pharm Bull. 2017;40:1174\u201382. https:\/\/doi.org\/10.1248\/bpb.b16-00777.","journal-title":"Biol Pharm Bull"},{"key":"1520_CR116","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01230-0","volume":"21","author":"Y Cen","year":"2023","unstructured":"Cen Y, Lou G, Qi J, Zheng M, Liu Y. A new perspective on mesenchymal stem cell-based therapy for liver diseases: restoring mitochondrial function. Cell Commun Signal. 2023;21:214. https:\/\/doi.org\/10.1186\/s12964-023-01230-0.","journal-title":"Cell Commun Signal"},{"key":"1520_CR117","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines8090350","author":"M-J Hsu","year":"2020","unstructured":"Hsu M-J, Karkossa I, Schaefer I, Christ M, Kuehne H, Schubert K, et al. Mitochondrial transfer by human mesenchymal stromal cells ameliorates hepatocyte lipid load in a mouse model of NASH. Biomedicines. 2020. https:\/\/doi.org\/10.3390\/biomedicines8090350.","journal-title":"Biomedicines."},{"key":"1520_CR118","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-021-02616-y","volume":"12","author":"SH Kim","year":"2021","unstructured":"Kim SH, Kim JY, Park SY, Jeong WT, Kim JM, Bae SH, et al. Activation of the EGFR-PI3K-CaM pathway by PRL-1-overexpressing placenta-derived mesenchymal stem cells ameliorates liver cirrhosis via ER stress-dependent calcium. Stem Cell Res Ther. 2021;12:551. https:\/\/doi.org\/10.1186\/s13287-021-02616-y.","journal-title":"Stem Cell Res Ther"},{"key":"1520_CR119","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-024-03466-0","volume":"22","author":"H Yuan","year":"2024","unstructured":"Yuan H, Liu Z, Chen M, Xu Q, Jiang Y, Zhang T, et al. Protein truncating variants in mitochondrial-related nuclear genes and the risk of chronic liver disease. BMC Med. 2024;22:239. https:\/\/doi.org\/10.1186\/s12916-024-03466-0.","journal-title":"BMC Med"},{"key":"1520_CR120","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.freeradbiomed.2025.02.045","volume":"231","author":"Z Xiong","year":"2025","unstructured":"Xiong Z, Chen P, Wang Z, Yao L, Yuan M, Liu P, et al. Human umbilical cord-derived mesenchymal stem cells attenuate liver fibrosis by inhibiting hepatocyte ferroptosis through mitochondrial transfer. Free Radic Biol Med. 2025;231:163\u201377. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2025.02.045.","journal-title":"Free Radic Biol Med"},{"key":"1520_CR121","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1186\/s13287-021-02663-5","volume":"12","author":"Y Bi","year":"2021","unstructured":"Bi Y, Guo X, Zhang M, Zhu K, Shi C, Fan B, et al. Bone marrow derived-mesenchymal stem cell improves diabetes-associated fatty liver via mitochondria transformation in mice. Stem Cell Res Ther. 2021;12:602. https:\/\/doi.org\/10.1186\/s13287-021-02663-5.","journal-title":"Stem Cell Res Ther"},{"key":"1520_CR122","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242115788","volume":"24","author":"AN Mukkala","year":"2023","unstructured":"Mukkala AN, Jerkic M, Khan Z, Szaszi K, Kapus A, Rotstein O. Therapeutic effects of mesenchymal stromal cells require mitochondrial transfer and quality control. Int J Mol Sci. 2023;24:15788. https:\/\/doi.org\/10.3390\/ijms242115788.","journal-title":"Int J Mol Sci"},{"key":"1520_CR123","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.653322","volume":"9","author":"MO Gomzikova","year":"2021","unstructured":"Gomzikova MO, James V, Rizvanov AA. Mitochondria donation by mesenchymal stem cells: current understanding and mitochondria transplantation strategies. Front Cell Dev Biol. 2021;9:653322. https:\/\/doi.org\/10.3389\/fcell.2021.653322.","journal-title":"Front Cell Dev Biol"},{"key":"1520_CR124","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nm.2736","volume":"18","author":"MN Islam","year":"2012","unstructured":"Islam MN, Das SR, Emin MT, Wei M, Sun L, Westphalen K, et al. Mitochondrial transfer from bone-marrow\u2013derived stromal cells to pulmonary alveoli protects against acute lung injury. Nat Med. 2012;18:759\u201365. https:\/\/doi.org\/10.1038\/nm.2736.","journal-title":"Nat Med"},{"key":"1520_CR125","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s00018-022-04207-3","volume":"79","author":"F Velarde","year":"2022","unstructured":"Velarde F, Ezquerra S, Delbruyere X, Caicedo A, Hidalgo Y, Khoury M. Mesenchymal stem cell-mediated transfer of mitochondria: mechanisms and functional impact. Cell Mol Life Sci. 2022;79:177. https:\/\/doi.org\/10.1007\/s00018-022-04207-3.","journal-title":"Cell Mol Life Sci"},{"key":"1520_CR126","doi-asserted-by":"publisher","first-page":"8472","DOI":"10.1038\/ncomms9472","volume":"6","author":"DG Phinney","year":"2015","unstructured":"Phinney DG, Di Giuseppe M, Njah J, Sala E, Shiva S, St Croix CM, et al. Mesenchymal stem cells use extracellular vesicles to outsource mitophagy and shuttle microRNAs. Nat Commun. 2015;6:8472. https:\/\/doi.org\/10.1038\/ncomms9472.","journal-title":"Nat Commun"},{"key":"1520_CR127","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1002\/stem.2372","volume":"34","author":"MV Jackson","year":"2016","unstructured":"Jackson MV, Morrison TJ, Doherty DF, McAuley DF, Matthay MA, Kissenpfennig A, et al. Mitochondrial transfer via tunneling nanotubes is an important mechanism by which mesenchymal stem cells enhance macrophage phagocytosis in the in vitro and in vivo models of ARDS. Stem Cells. 2016;34:2210\u201323. https:\/\/doi.org\/10.1002\/stem.2372.","journal-title":"Stem Cells"},{"key":"1520_CR128","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1164\/rccm.201701-0170OC","volume":"196","author":"TJ Morrison","year":"2017","unstructured":"Morrison TJ, Jackson MV, Cunningham EK, Kissenpfennig A, McAuley DF, O\u2019Kane CM, et al. Mesenchymal stromal cells modulate macrophages in clinically relevant lung injury models by extracellular vesicle mitochondrial transfer. Am J Respir Crit Care Med. 2017;196:1275\u201386. https:\/\/doi.org\/10.1164\/rccm.201701-0170OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"1520_CR129","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201948052","volume":"21","author":"AC Court","year":"2020","unstructured":"Court AC, Le\u2010Gatt A, Luz\u2010Crawford P, Parra E, Aliaga\u2010Tobar V, B\u00e1tiz LF, et al. Mitochondrial transfer from MSCs to T cells induces Treg differentiation and restricts inflammatory response. EMBO Rep. 2020;21:e48052. https:\/\/doi.org\/10.15252\/embr.201948052.","journal-title":"EMBO Rep"},{"key":"1520_CR130","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s13287-019-1307-9","volume":"10","author":"P Luz-Crawford","year":"2019","unstructured":"Luz-Crawford P, Hernandez J, Djouad F, Luque-Campos N, Caicedo A, Carr\u00e8re-Kremer S, et al. Mesenchymal stem cell repression of Th17 cells is triggered by mitochondrial transfer. Stem Cell Res Ther. 2019;10:232. https:\/\/doi.org\/10.1186\/s13287-019-1307-9.","journal-title":"Stem Cell Res Ther"},{"key":"1520_CR131","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41581-018-0023-5","volume":"14","author":"Y Shi","year":"2018","unstructured":"Shi Y, Wang Y, Li Q, Liu K, Hou J, Shao C, et al. Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases. Nat Rev Nephrol. 2018;14:493\u2013507. https:\/\/doi.org\/10.1038\/s41581-018-0023-5.","journal-title":"Nat Rev Nephrol"},{"key":"1520_CR132","doi-asserted-by":"publisher","first-page":"3838","DOI":"10.1182\/blood.V99.10.3838","volume":"99","author":"M Di Nicola","year":"2002","unstructured":"Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, Matteucci P, et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood. 2002;99:3838\u201343. https:\/\/doi.org\/10.1182\/blood.V99.10.3838.","journal-title":"Blood"},{"key":"1520_CR133","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12712","volume":"53","author":"W Jiang","year":"2020","unstructured":"Jiang W, Xu J. Immune modulation by mesenchymal stem cells. Cell Prolif. 2020;53:e12712. https:\/\/doi.org\/10.1111\/cpr.12712.","journal-title":"Cell Prolif"},{"key":"1520_CR134","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-024-04127-y","volume":"16","author":"W-C Huang","year":"2025","unstructured":"Huang W-C, Li Y-C, Chen P-X, Ma KS-K, Wang L-T. Mesenchymal stem cell therapy as a game-changer in liver diseases: review of current clinical trials. Stem Cell Res Ther. 2025;16:3. https:\/\/doi.org\/10.1186\/s13287-024-04127-y.","journal-title":"Stem Cell Res Ther"},{"key":"1520_CR135","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1093\/stcltm\/szab020","volume":"11","author":"\u00c9 Mezey","year":"2022","unstructured":"Mezey \u00c9. Human mesenchymal stem\/stromal cells in immune regulation and therapy. Stem Cells Transl Med. 2022;11:114\u201334. https:\/\/doi.org\/10.1093\/stcltm\/szab020.","journal-title":"Stem Cells Transl Med"},{"key":"1520_CR136","doi-asserted-by":"publisher","first-page":"4091","DOI":"10.1172\/JCI122258","volume":"129","author":"CJ Calvente","year":"2019","unstructured":"Calvente CJ, Tameda M, Johnson CD, Del Pilar H, Lin YC, Adronikou N, et al. Neutrophils contribute to spontaneous resolution of liver inflammation and fibrosis via microRNA-223. J Clin Invest. 2019;129:4091\u2013109. https:\/\/doi.org\/10.1172\/JCI122258.","journal-title":"J Clin Invest"},{"key":"1520_CR137","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s00109-019-01776-y","volume":"97","author":"LL de Castro","year":"2019","unstructured":"de Castro LL, Lopes-Pacheco M, Weiss DJ, Cruz FF, Rocco PRM. Current understanding of the immunosuppressive properties of mesenchymal stromal cells. J Mol Med (Berl). 2019;97:605\u201318. https:\/\/doi.org\/10.1007\/s00109-019-01776-y.","journal-title":"J Mol Med (Berl)"},{"key":"1520_CR138","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1189\/jlb.0410207","volume":"88","author":"S Brandau","year":"2010","unstructured":"Brandau S, Jakob M, Hemeda H, Bruderek K, Janeschik S, Bootz F, et al. Tissue-resident mesenchymal stem cells attract peripheral blood neutrophils and enhance their inflammatory activity in response to microbial challenge. J Leukoc Biol. 2010;88:1005\u201315. https:\/\/doi.org\/10.1189\/jlb.0410207.","journal-title":"J Leukoc Biol"},{"key":"1520_CR139","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0155161","volume":"11","author":"H Munir","year":"2016","unstructured":"Munir H, Luu N-T, Clarke LSC, Nash GB, McGettrick HM. Comparative ability of mesenchymal stromal cells from different tissues to limit neutrophil recruitment to inflamed endothelium. PLoS ONE. 2016;11:e0155161. https:\/\/doi.org\/10.1371\/journal.pone.0155161.","journal-title":"PLoS ONE"},{"key":"1520_CR140","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1634\/stemcells.2007-0416","volume":"26","author":"L Raffaghello","year":"2008","unstructured":"Raffaghello L, Bianchi G, Bertolotto M, Montecucco F, Busca A, Dallegri F, et al. Human mesenchymal stem cells inhibit neutrophil apoptosis: a model for neutrophil preservation in the bone marrow niche. Stem Cells. 2008;26:151\u201362. https:\/\/doi.org\/10.1634\/stemcells.2007-0416.","journal-title":"Stem Cells"},{"key":"1520_CR141","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/j.jhep.2015.07.035","volume":"63","author":"K-C Lee","year":"2015","unstructured":"Lee K-C, Lin H-C, Huang Y-H, Hung S-C. Allo-transplantation of mesenchymal stem cells attenuates hepatic injury through IL1Ra dependent macrophage switch in a mouse model of liver disease. J Hepatol. 2015;63:1405\u201312. https:\/\/doi.org\/10.1016\/j.jhep.2015.07.035.","journal-title":"J Hepatol"},{"key":"1520_CR142","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1002\/stem.1191","volume":"30","author":"JH Yl\u00d6stalo","year":"2012","unstructured":"Yl\u00d6stalo JH, Bartosh TJ, Coble K, Prockop DJ. Human mesenchymal stem\/stromal cells cultured as spheroids are self-activated to produce prostaglandin E2 that directs stimulated macrophages into an anti-inflammatory phenotype. Stem Cells. 2012;30:2283\u201396. https:\/\/doi.org\/10.1002\/stem.1191.","journal-title":"Stem Cells"},{"key":"1520_CR143","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.imbio.2019.04.002","volume":"224","author":"RB\u00d6 \u00d6zdemir","year":"2019","unstructured":"\u00d6zdemir RB\u00d6, \u00d6zdemir AT, Sar\u0131boyac\u0131 AE, Uysal O, Tu\u011flu M\u0130, K\u0131rmaz C. The investigation of immunomodulatory effects of adipose tissue mesenchymal stem cell educated macrophages on the CD4 T cells. Immunobiology. 2019;224:585\u201394. https:\/\/doi.org\/10.1016\/j.imbio.2019.04.002.","journal-title":"Immunobiology"},{"key":"1520_CR144","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-018-1122-8","volume":"10","author":"X-Y Luo","year":"2019","unstructured":"Luo X-Y, Meng X-J, Cao D-C, Wang W, Zhou K, Li L, et al. Transplantation of bone marrow mesenchymal stromal cells attenuates liver fibrosis in mice by regulating macrophage subtypes. Stem Cell Res Ther. 2019;10:16. https:\/\/doi.org\/10.1186\/s13287-018-1122-8.","journal-title":"Stem Cell Res Ther"},{"key":"1520_CR145","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009252","volume":"5","author":"J Maggini","year":"2010","unstructured":"Maggini J, Mirkin G, Bognanni I, Holmberg J, Piazz\u00f3n IM, Nepomnaschy I, et al. Mouse bone marrow-derived mesenchymal stromal cells turn activated macrophages into a regulatory-like profile. PLoS ONE. 2010;5:e9252. https:\/\/doi.org\/10.1371\/journal.pone.0009252.","journal-title":"PLoS ONE"},{"key":"1520_CR146","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.bbadis.2013.01.005","volume":"1832","author":"AH Rahman","year":"2013","unstructured":"Rahman AH, Aloman C. Dendritic cells and liver fibrosis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2013;1832:998\u20131004. https:\/\/doi.org\/10.1016\/j.bbadis.2013.01.005.","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"},{"key":"1520_CR147","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2174\/1574888X10666150904114035","volume":"11","author":"JM \u00d0oki\u0107","year":"2016","unstructured":"\u00d0oki\u0107 JM, Tomi\u0107 SZ, \u010coli\u0107 MJ. Cross-talk between mesenchymal stem\/stromal cells and dendritic cells. Curr Stem Cell Res Ther. 2016;11:51\u201365.","journal-title":"Curr Stem Cell Res Ther"},{"key":"1520_CR148","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.imlet.2007.10.002","volume":"115","author":"K English","year":"2008","unstructured":"English K, Barry FP, Mahon BP. Murine mesenchymal stem cells suppress dendritic cell migration, maturation and antigen presentation. Immunol Lett. 2008;115:50\u20138. https:\/\/doi.org\/10.1016\/j.imlet.2007.10.002.","journal-title":"Immunol Lett"},{"key":"1520_CR149","doi-asserted-by":"publisher","first-page":"4120","DOI":"10.1182\/blood-2004-02-0586","volume":"105","author":"X-X Jiang","year":"2005","unstructured":"Jiang X-X, Zhang Y, Liu B, Zhang S-X, Wu Y, Yu X-D, et al. Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood. 2005;105:4120\u20136. https:\/\/doi.org\/10.1182\/blood-2004-02-0586.","journal-title":"Blood"},{"key":"1520_CR150","doi-asserted-by":"publisher","first-page":"6576","DOI":"10.1182\/blood-2009-02-203943","volume":"113","author":"GM Spaggiari","year":"2009","unstructured":"Spaggiari GM, Abdelrazik H, Becchetti F, Moretta L. MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2. Blood. 2009;113:6576\u201383. https:\/\/doi.org\/10.1182\/blood-2009-02-203943.","journal-title":"Blood"},{"key":"1520_CR151","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1038\/icb.2010.47","volume":"88","author":"S Tipnis","year":"2010","unstructured":"Tipnis S, Viswanathan C, Majumdar AS. Immunosuppressive properties of human umbilical cord-derived mesenchymal stem cells: role of B7\u2013H1 and IDO. Immunol Cell Biol. 2010;88:795\u2013806. https:\/\/doi.org\/10.1038\/icb.2010.47.","journal-title":"Immunol Cell Biol"},{"key":"1520_CR152","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.108643","volume":"107","author":"L Wu","year":"2022","unstructured":"Wu L, Cao H, Tian X, Zheng W, Yuan M, Li X, et al. Bone marrow mesenchymal stem cells modified with heme oxygenase-1 alleviate rejection of donation after circulatory death liver transplantation by inhibiting dendritic cell maturation in rats. Int Immunopharmacol. 2022;107:108643. https:\/\/doi.org\/10.1016\/j.intimp.2022.108643.","journal-title":"Int Immunopharmacol"},{"key":"1520_CR153","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.4049\/jimmunol.180.3.1598","volume":"180","author":"Y-P Li","year":"2008","unstructured":"Li Y-P, Paczesny S, Lauret E, Poirault S, Bordigoni P, Mekhloufi F, et al. Human mesenchymal stem cells license adult CD34+ hemopoietic progenitor cells to differentiate into regulatory dendritic cells through activation of the Notch pathway. J Immunol. 2008;180:1598\u2013608. https:\/\/doi.org\/10.4049\/jimmunol.180.3.1598.","journal-title":"J Immunol"},{"key":"1520_CR154","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/hep.26670","volume":"59","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Cai W, Huang Q, Gu Y, Shi Y, Huang J, et al. Mesenchymal stem cells alleviate bacteria-induced liver injury in mice by inducing regulatory dendritic cells. Hepatology. 2014;59:671\u201382. https:\/\/doi.org\/10.1002\/hep.26670.","journal-title":"Hepatology"},{"key":"1520_CR155","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1634\/stemcells.2004-0359","volume":"24","author":"PA Sotiropoulou","year":"2006","unstructured":"Sotiropoulou PA, Perez SA, Gritzapis AD, Baxevanis CN, Papamichail M. Interactions between human mesenchymal stem cells and natural killer cells. Stem Cells. 2006;24:74\u201385. https:\/\/doi.org\/10.1634\/stemcells.2004-0359.","journal-title":"Stem Cells"},{"key":"1520_CR156","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1182\/blood-2007-02-074997","volume":"111","author":"GM Spaggiari","year":"2008","unstructured":"Spaggiari GM, Capobianco A, Abdelrazik H, Becchetti F, Mingari MC, Moretta L. Mesenchymal stem cells inhibit natural killer\u2013cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2. Blood. 2008;111:1327\u201333. https:\/\/doi.org\/10.1182\/blood-2007-02-074997.","journal-title":"Blood"},{"key":"1520_CR157","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1182\/blood-2005-07-2775","volume":"107","author":"GM Spaggiari","year":"2006","unstructured":"Spaggiari GM, Capobianco A, Becchetti S, Mingari MC, Moretta L. Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. Blood. 2006;107:1484\u201390. https:\/\/doi.org\/10.1182\/blood-2005-07-2775.","journal-title":"Blood"},{"key":"1520_CR158","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1182\/blood-2013-09-524827","volume":"123","author":"D Chatterjee","year":"2014","unstructured":"Chatterjee D, Tufa DM, Baehre H, Hass R, Schmidt RE, Jacobs R. Natural killer cells acquire CD73 expression upon exposure to mesenchymal stem cells. Blood. 2014;123:594\u20135. https:\/\/doi.org\/10.1182\/blood-2013-09-524827.","journal-title":"Blood"},{"key":"1520_CR159","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1182\/blood-2004-04-1559","volume":"105","author":"S Aggarwal","year":"2005","unstructured":"Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood. 2005;105:1815\u201322. https:\/\/doi.org\/10.1182\/blood-2004-04-1559.","journal-title":"Blood"},{"key":"1520_CR160","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/7495135","volume":"2016","author":"X Li","year":"2016","unstructured":"Li X, Xu Z, Bai J, Yang S, Zhao S, Zhang Y, et al. Umbilical cord tissue-derived mesenchymal stem cells induce T lymphocyte apoptosis and cell cycle arrest by expression of indoleamine 2, 3-dioxygenase. Stem Cells International. 2016;2016:1\u201311. https:\/\/doi.org\/10.1155\/2016\/7495135.","journal-title":"Stem Cells International"},{"key":"1520_CR161","doi-asserted-by":"publisher","first-page":"4619","DOI":"10.1182\/blood-2003-11-3909","volume":"103","author":"R Meisel","year":"2004","unstructured":"Meisel R, Zibert A, Laryea M, G\u00f6bel U, D\u00e4ubener W, Dilloo D. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase\u2013mediated tryptophan degradation. Blood. 2004;103:4619\u201321. https:\/\/doi.org\/10.1182\/blood-2003-11-3909.","journal-title":"Blood"},{"key":"1520_CR162","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1182\/blood-2006-02-002246","volume":"109","author":"K Sato","year":"2007","unstructured":"Sato K, Ozaki K, Oh I, Meguro A, Hatanaka K, Nagai T, et al. Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells. Blood. 2007;109:228\u201334. https:\/\/doi.org\/10.1182\/blood-2006-02-002246.","journal-title":"Blood"},{"key":"1520_CR163","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.2337\/db09-0317","volume":"58","author":"Y Ding","year":"2009","unstructured":"Ding Y, Xu D, Feng G, Bushell A, Muschel RJ, Wood KJ. Mesenchymal stem cells prevent the rejection of fully allogenic islet grafts by the immunosuppressive activity of matrix metalloproteinase-2 and -9. Diabetes. 2009;58:1797\u2013806. https:\/\/doi.org\/10.2337\/db09-0317.","journal-title":"Diabetes"},{"key":"1520_CR164","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1002\/stem.2509","volume":"35","author":"LC Davies","year":"2017","unstructured":"Davies LC, Heldring N, Kadri N, Le Blanc K. Mesenchymal stromal cell secretion of programmed death-1 ligands regulates T cell mediated immunosuppression. Stem Cells. 2017;35:766\u201376. https:\/\/doi.org\/10.1002\/stem.2509.","journal-title":"Stem Cells"},{"key":"1520_CR165","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.exphem.2007.11.007","volume":"36","author":"M Di Ianni","year":"2008","unstructured":"Di Ianni M, Del Papa B, De Ioanni M, Moretti L, Bonifacio E, Cecchini D, et al. Mesenchymal cells recruit and regulate T regulatory cells. Exp Hematol. 2008;36:309\u201318. https:\/\/doi.org\/10.1016\/j.exphem.2007.11.007.","journal-title":"Exp Hematol"},{"key":"1520_CR166","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1002\/stem.3151","volume":"38","author":"N Negi","year":"2020","unstructured":"Negi N, Griffin MD. Effects of mesenchymal stromal cells on regulatory T cells: current understanding and clinical relevance. Stem Cells. 2020;38:596\u2013605. https:\/\/doi.org\/10.1002\/stem.3151.","journal-title":"Stem Cells"},{"key":"1520_CR167","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1007\/s12015-014-9558-4","volume":"11","author":"S Pianta","year":"2015","unstructured":"Pianta S, Signoroni PB, Muradore I, Rodrigues MF, Rossi D, Silini A, et al. Amniotic membrane mesenchymal cells-derived factors skew T cell polarization toward Treg and downregulate Th1 and Th17 cells subsets. Stem Cell Rev Rep. 2015;11:394\u2013407. https:\/\/doi.org\/10.1007\/s12015-014-9558-4.","journal-title":"Stem Cell Rev Rep"},{"key":"1520_CR168","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-021-02430-6","author":"Y Xie","year":"2021","unstructured":"Xie Y, Liu S, Wang L, Yang H, Tai C, Ling L, et al. Individual heterogeneity screened umbilical cord-derived mesenchymal stromal cells with high Treg promotion demonstrate improved recovery of mouse liver fibrosis. Stem Cell Res Ther. 2021. https:\/\/doi.org\/10.1186\/s13287-021-02430-6.","journal-title":"Stem Cell Res Ther"},{"key":"1520_CR169","doi-asserted-by":"publisher","first-page":"881","DOI":"10.3324\/haematol.11240","volume":"92","author":"C Prevosto","year":"2007","unstructured":"Prevosto C, Zancolli M, Canevali P, Zocchi MR, Poggi A. Generation of CD4+ or CD8+ regulatory T cells upon mesenchymal stem cell-lymphocyte interaction. Haematologica. 2007;92:881\u20138. https:\/\/doi.org\/10.3324\/haematol.11240.","journal-title":"Haematologica"},{"key":"1520_CR170","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-020-01612-y","volume":"11","author":"Q-H Chen","year":"2020","unstructured":"Chen Q-H, Wu F, Liu L, Chen H, Zheng R-Q, Wang H-L, et al. Mesenchymal stem cells regulate the Th17\/Treg cell balance partly through hepatocyte growth factor in vitro. Stem Cell Res Ther. 2020;11:91. https:\/\/doi.org\/10.1186\/s13287-020-01612-y.","journal-title":"Stem Cell Res Ther"},{"key":"1520_CR171","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/j.1365-2249.2009.03874.x","volume":"156","author":"K English","year":"2009","unstructured":"English K, Ryan JM, Tobin L, Murphy MJ, Barry FP, Mahon BP. Cell contact, prostaglandin E2 and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25Highforkhead box P3+ regulatory T cells. Clin Exp Immunol. 2009;156:149\u201360. https:\/\/doi.org\/10.1111\/j.1365-2249.2009.03874.x.","journal-title":"Clin Exp Immunol"},{"key":"1520_CR172","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.cellimm.2016.12.006","volume":"313","author":"Z-Y Shen","year":"2017","unstructured":"Shen Z-Y, Wu B, Liu T, Yang Y, Yin M-L, Zheng W-P, et al. Immunomodulatory effects of bone marrow mesenchymal stem cells overexpressing heme oxygenase-1: protective effects on acute rejection following reduced-size liver transplantation in a rat model. Cell Immunol. 2017;313:10\u201324. https:\/\/doi.org\/10.1016\/j.cellimm.2016.12.006.","journal-title":"Cell Immunol"},{"key":"1520_CR173","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/stem.2485","volume":"35","author":"I Rashedi","year":"2017","unstructured":"Rashedi I, G\u00f3mez-Aristiz\u00e1bal A, Wang X-H, Viswanathan S, Keating A. TLR3 or TLR4 activation enhances mesenchymal stromal cell-mediated Treg induction via Notch signaling. Stem Cells. 2017;35:265\u201375. https:\/\/doi.org\/10.1002\/stem.2485.","journal-title":"Stem Cells"},{"key":"1520_CR174","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1002\/stem.1432","volume":"31","author":"SM Melief","year":"2013","unstructured":"Melief SM, Schrama E, Brugman MH, Tiemessen MM, Hoogduijn MJ, Fibbe WE, et al. Multipotent stromal cells induce human regulatory T cells through a novel pathway involving skewing of monocytes toward anti-inflammatory macrophages. Stem Cells. 2013;31:1980\u201391. https:\/\/doi.org\/10.1002\/stem.1432.","journal-title":"Stem Cells"},{"key":"1520_CR175","doi-asserted-by":"publisher","first-page":"19446","DOI":"10.1073\/pnas.0706832104","volume":"104","author":"MM Tiemessen","year":"2007","unstructured":"Tiemessen MM, Jagger AL, Evans HG, van Herwijnen MJC, John S, Taams LS. CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes\/macrophages. Proc Natl Acad Sci U S A. 2007;104:19446\u201351. https:\/\/doi.org\/10.1073\/pnas.0706832104.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1520_CR176","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000831","author":"X Feng","year":"2024","unstructured":"Feng X, Feng B, Zhou J, Yang J, Pan Q, Yu J, et al. Mesenchymal stem cells alleviate mouse liver fibrosis by inhibiting pathogenic function of intrahepatic B cells. Hepatology. 2024. https:\/\/doi.org\/10.1097\/HEP.0000000000000831.","journal-title":"Hepatology"},{"key":"1520_CR177","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17050650","volume":"17","author":"L Fan","year":"2016","unstructured":"Fan L, Hu C, Chen J, Cen P, Wang J, Li L. Interaction between mesenchymal stem cells and B-cells. Int J Mol Sci. 2016;17:650. https:\/\/doi.org\/10.3390\/ijms17050650.","journal-title":"Int J Mol Sci"},{"key":"1520_CR178","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41423-023-00983-5","volume":"20","author":"X Yang","year":"2023","unstructured":"Yang X, Li Q, Liu W, Zong C, Wei L, Shi Y, et al. Mesenchymal stromal cells in hepatic fibrosis\/cirrhosis: from pathogenesis to treatment. Cell Mol Immunol. 2023;20:583\u201399. https:\/\/doi.org\/10.1038\/s41423-023-00983-5.","journal-title":"Cell Mol Immunol"},{"key":"1520_CR179","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.lfs.2011.10.012","volume":"89","author":"S Chen","year":"2011","unstructured":"Chen S, Xu L, Lin N, Pan W, Hu K, Xu R. Activation of Notch1 signaling by marrow-derived mesenchymal stem cells through cell\u2013cell contact inhibits proliferation of hepatic stellate cells. Life Sci. 2011;89:975\u201381. https:\/\/doi.org\/10.1016\/j.lfs.2011.10.012.","journal-title":"Life Sci"},{"key":"1520_CR180","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0043408","volume":"7","author":"P Wang","year":"2012","unstructured":"Wang P, Xie D, Liang X-J, Peng L, Zhang G, Ye Y, et al. HGF and direct mesenchymal stem cells contact synergize to inhibit hepatic stellate cells activation through TLR4\/NF-kB pathway. PLoS ONE. 2012;7:e43408. https:\/\/doi.org\/10.1371\/journal.pone.0043408.","journal-title":"PLoS ONE"},{"key":"1520_CR181","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.bbrc.2007.05.150","volume":"363","author":"B Parekkadan","year":"2007","unstructured":"Parekkadan B, Van Poll D, Megeed Z, Kobayashi N, Tilles AW, Berthiaume F, et al. Immunomodulation of activated hepatic stellate cells by mesenchymal stem cells. Biochem Biophys Res Commun. 2007;363:247\u201352. https:\/\/doi.org\/10.1016\/j.bbrc.2007.05.150.","journal-title":"Biochem Biophys Res Commun"},{"key":"1520_CR182","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.1007\/s10620-008-0227-9","volume":"53","author":"L Shi","year":"2008","unstructured":"Shi L, Li G, Wang J, Sun B, Yang L, Wang G, et al. Bone marrow stromal cells control the growth of hepatic stellate cells in vitro. Dig Dis Sci. 2008;53:2969\u201374. https:\/\/doi.org\/10.1007\/s10620-008-0227-9.","journal-title":"Dig Dis Sci"},{"key":"1520_CR183","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1111\/j.1872-034X.2009.00564.x","volume":"39","author":"J Wang","year":"2009","unstructured":"Wang J, Bian C, Liao L, Zhu Y, Li J, Zeng L, et al. Inhibition of hepatic stellate cells proliferation by mesenchymal stem cells and the possible mechanisms. Hepatol Res. 2009;39:1219\u201328. https:\/\/doi.org\/10.1111\/j.1872-034X.2009.00564.x.","journal-title":"Hepatol Res"},{"key":"1520_CR184","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1053\/j.gastro.2016.12.003","volume":"152","author":"SY An","year":"2017","unstructured":"An SY, Jang YJ, Lim H-J, Han J, Lee J, Lee G, et al. Milk fat globule-EGF factor 8, secreted by mesenchymal stem cells, protects against liver fibrosis in mice. Gastroenterology. 2017;152:1174\u201386. https:\/\/doi.org\/10.1053\/j.gastro.2016.12.003.","journal-title":"Gastroenterology"},{"key":"1520_CR185","doi-asserted-by":"publisher","DOI":"10.3390\/cells8111419","volume":"8","author":"B Dewidar","year":"2019","unstructured":"Dewidar B, Meyer C, Dooley S, Meindl-Beinker N. TGF-\u03b2 in hepatic stellate cell activation and liver fibrogenesis-updated 2019. Cells. 2019;8:1419. https:\/\/doi.org\/10.3390\/cells8111419.","journal-title":"Cells"},{"key":"1520_CR186","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2018.3500","author":"L-T Zhang","year":"2018","unstructured":"Zhang L-T, Peng X-B, Fang X-Q, Li J-F, Chen H, Mao X-R. Human umbilical cord mesenchymal stem cells inhibit proliferation of hepatic stellate cells in vitro. Int J Mol Med. 2018. https:\/\/doi.org\/10.3892\/ijmm.2018.3500.","journal-title":"Int J Mol Med"},{"key":"1520_CR187","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-025-04353-y","volume":"16","author":"Z Si","year":"2025","unstructured":"Si Z, Zhao S, Zhang Z, Chen T, Wang R, Dong C, et al. Bone marrow mesenchymal stem cells alleviate liver fibrosis after rat liver transplantation through JAK1\/STAT5 pathway. Stem Cell Res Ther. 2025;16:217. https:\/\/doi.org\/10.1186\/s13287-025-04353-y.","journal-title":"Stem Cell Res Ther"},{"key":"1520_CR188","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.lfs.2009.06.007","volume":"85","author":"N Lin","year":"2009","unstructured":"Lin N, Hu K, Chen S, Xie S, Tang Z, Lin J, et al. Nerve growth factor-mediated paracrine regulation of hepatic stellate cells by multipotent mesenchymal stromal cells. Life Sci. 2009;85:291\u20135. https:\/\/doi.org\/10.1016\/j.lfs.2009.06.007.","journal-title":"Life Sci"},{"key":"1520_CR189","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1096402","volume":"13","author":"P Liu","year":"2023","unstructured":"Liu P, Qian Y, Liu X, Zhu X, Zhang X, Lv Y, et al. Immunomodulatory role of mesenchymal stem cell therapy in liver fibrosis. Front Immunol. 2023;13:1096402. https:\/\/doi.org\/10.3389\/fimmu.2022.1096402.","journal-title":"Front Immunol"},{"key":"1520_CR190","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/hep.21477","volume":"45","author":"R Higashiyama","year":"2007","unstructured":"Higashiyama R, Inagaki Y, Hong YY, Kushida M, Nakao S, Niioka M, et al. Bone marrow\u2013derived cells express matrix metalloproteinases and contribute to regression of liver fibrosis in mice. Hepatology. 2007;45:213\u201322. https:\/\/doi.org\/10.1002\/hep.21477.","journal-title":"Hepatology"},{"key":"1520_CR191","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-43298-0","volume":"9","author":"N Itaba","year":"2019","unstructured":"Itaba N, Kono Y, Watanabe K, Yokobata T, Oka H, Osaki M, et al. Reversal of established liver fibrosis by IC-2-engineered mesenchymal stem cell sheets. Sci Rep. 2019;9:6841. https:\/\/doi.org\/10.1038\/s41598-019-43298-0.","journal-title":"Sci Rep"},{"key":"1520_CR192","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.jhep.2014.10.030","volume":"62","author":"RPH Meier","year":"2015","unstructured":"Meier RPH, Mahou R, Morel P, Meyer J, Montanari E, Muller YD, et al. Microencapsulated human mesenchymal stem cells decrease liver fibrosis in mice. J Hepatol. 2015;62:634\u201341. https:\/\/doi.org\/10.1016\/j.jhep.2014.10.030.","journal-title":"J Hepatol"},{"key":"1520_CR193","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/jcp.22344","volume":"226","author":"TP Lozito","year":"2011","unstructured":"Lozito TP, Tuan RS. Mesenchymal stem cells inhibit both endogenous and exogenous MMPs via secreted TIMPs. J Cell Physiol. 2011;226:385\u201396. https:\/\/doi.org\/10.1002\/jcp.22344.","journal-title":"J Cell Physiol"},{"key":"1520_CR194","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-020-01911-4","author":"D-N Su","year":"2020","unstructured":"Su D-N, Wu S-P, Xu S-Z. Mesenchymal stem cell-based Smad7 gene therapy for experimental liver cirrhosis. Stem Cell Res Ther. 2020. https:\/\/doi.org\/10.1186\/s13287-020-01911-4.","journal-title":"Stem Cell Res Ther"},{"key":"1520_CR195","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/resp.13928","volume":"26","author":"S Periera\u2010Simon","year":"2021","unstructured":"Periera\u2010Simon S, Xia X, Catanuto P, Coronado R, Kurtzberg J, Bellio M, et al. Anti\u2010fibrotic effects of different sources of MSC in bleomycin-induced lung fibrosis in C57BL6 male mice. Respirology. 2021;26:161\u201370. https:\/\/doi.org\/10.1111\/resp.13928.","journal-title":"Respirology"},{"key":"1520_CR196","doi-asserted-by":"publisher","DOI":"10.1088\/1758-5090\/ad304d","author":"M Yan","year":"2024","unstructured":"Yan M, Yao J, Xie Y, Jiang P, Yan J, Li X. Bioreactor-based stem cell therapy for liver fibrosis. Biofabrication. 2024. https:\/\/doi.org\/10.1088\/1758-5090\/ad304d.","journal-title":"Biofabrication"},{"key":"1520_CR197","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01735-1","author":"MA Kumar","year":"2024","unstructured":"Kumar MA, Baba SK, Sadida HQ, Marzooqi SA, Jerobin J, Altemani FH, et al. Extracellular vesicles as tools and targets in therapy for diseases. Signal Transduct Target Ther. 2024. https:\/\/doi.org\/10.1038\/s41392-024-01735-1.","journal-title":"Signal Transduct Target Ther"},{"key":"1520_CR198","doi-asserted-by":"publisher","DOI":"10.1007\/s13346-024-01784-7","author":"MA Didamoony","year":"2025","unstructured":"Didamoony MA, Soubh AA, Ahmed LA. Cutting-edge insights into liver fibrosis: advanced therapeutic strategies and future perspectives using engineered mesenchymal stem cell-derived exosomes. Drug Deliv Transl Res. 2025. https:\/\/doi.org\/10.1007\/s13346-024-01784-7.","journal-title":"Drug Deliv Transl Res"},{"key":"1520_CR199","doi-asserted-by":"publisher","first-page":"216","DOI":"10.20517\/evcna.2025.08","volume":"6","author":"G Chiabotto","year":"2025","unstructured":"Chiabotto G, Semnani A, Ceccotti E, Bruno S. Extracellular vesicles: emerging therapeutic agents for liver fibrosis. Extracell Vesicles Circ Nucleic Acids. 2025;6:216\u201344. https:\/\/doi.org\/10.20517\/evcna.2025.08.","journal-title":"Extracell Vesicles Circ Nucleic Acids"},{"key":"1520_CR200","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1007\/s12015-021-10313-9","volume":"18","author":"S Gupta","year":"2022","unstructured":"Gupta S, Pinky, Vishay, Sharma H, Soni N, Rao EP, et al. Comparative evaluation of anti-fibrotic effect of tissue specific mesenchymal stem cells derived extracellular vesicles for the amelioration of CCl4 induced chronic liver injury. Stem Cell Rev Rep. 2022;18:1097\u2013112. https:\/\/doi.org\/10.1007\/s12015-021-10313-9.","journal-title":"Stem Cell Rev Rep."},{"key":"1520_CR201","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112934","volume":"141","author":"HA Al Saihati","year":"2024","unstructured":"Al Saihati HA, Badr OA, Dessouky AA, Mostafa O, Samir Farid A, Aborayah NH, et al. Exploring the cytoprotective role of mesenchymal stem cell-derived exosomes in chronic liver fibrosis: insights into the Nrf2\/Keap1\/p62 signaling pathway. Int Immunopharmacol. 2024;141:112934. https:\/\/doi.org\/10.1016\/j.intimp.2024.112934.","journal-title":"Int Immunopharmacol"},{"key":"1520_CR202","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajps.2024.100889","volume":"19","author":"W Chen","year":"2024","unstructured":"Chen W, Lin F, Feng X, Yao Q, Yu Y, Gao F, et al. MSC-derived exosomes attenuate hepatic fibrosis in primary sclerosing cholangitis through inhibition of Th17 differentiation. Asian J Pharm Sci. 2024;19:100889. https:\/\/doi.org\/10.1016\/j.ajps.2024.100889.","journal-title":"Asian J Pharm Sci"},{"key":"1520_CR203","doi-asserted-by":"publisher","DOI":"10.3390\/ncrna10040044","volume":"10","author":"R Gao","year":"2024","unstructured":"Gao R, Mao J. Noncoding RNA-mediated epigenetic regulation in hepatic stellate cells of liver fibrosis. Non-coding RNA. 2024;10:44. https:\/\/doi.org\/10.3390\/ncrna10040044.","journal-title":"Non-coding RNA"},{"key":"1520_CR204","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.114040","volume":"157","author":"C Wang","year":"2023","unstructured":"Wang C, Zhou H, Wu R, Guo Y, Gong L, Fu K, et al. Mesenchymal stem cell-derived exosomes and non-coding RNAs: regulatory and therapeutic role in liver diseases. Biomed Pharmacother. 2023;157:114040. https:\/\/doi.org\/10.1016\/j.biopha.2022.114040.","journal-title":"Biomed Pharmacother"},{"key":"1520_CR205","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s10529-025-03579-3","volume":"47","author":"M-S Choi","year":"2025","unstructured":"Choi M-S, Hong J-S, Lee D-H, Jang YJ, Kim J-H, Lee YS. Anti-liver fibrotic effects of small extracellular vesicle microRNAs from human umbilical cord-derived mesenchymal stem cells and their differentiated hepatocyte-like cells. Biotechnol Lett. 2025;47:38. https:\/\/doi.org\/10.1007\/s10529-025-03579-3.","journal-title":"Biotechnol Lett"},{"key":"1520_CR206","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.3390\/cells9051272","volume":"9","author":"N Basalova","year":"2020","unstructured":"Basalova N, Sagaradze G, Arbatskiy M, Evtushenko E, Kulebyakin K, Grigorieva O, et al. Secretome of mesenchymal stromal cells prevents myofibroblasts differentiation by transferring fibrosis-associated microRNAs within extracellular vesicles. Cells. 2020;9:1272. https:\/\/doi.org\/10.3390\/cells9051272.","journal-title":"Cells"},{"key":"1520_CR207","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1080\/21623945.2022.2098583","volume":"11","author":"Q Niu","year":"2022","unstructured":"Niu Q, Wang T, Wang Z, Wang F, Huang D, Sun H, et al. Adipose-derived mesenchymal stem cell-secreted extracellular vesicles alleviate non-alcoholic fatty liver disease via delivering miR-223-3p. Adipocyte. 2022;11:572\u201387. https:\/\/doi.org\/10.1080\/21623945.2022.2098583.","journal-title":"Adipocyte"},{"key":"1520_CR208","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2021.114624","volume":"190","author":"MO El-Derany","year":"2021","unstructured":"El-Derany MO, AbdelHamid SG. Upregulation of miR-96-5p by bone marrow mesenchymal stem cells and their exosomes alleviate non-alcoholic steatohepatitis: emphasis on caspase-2 signaling inhibition. Biochem Pharmacol. 2021;190:114624. https:\/\/doi.org\/10.1016\/j.bcp.2021.114624.","journal-title":"Biochem Pharmacol"},{"key":"1520_CR209","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13287-025-04197-6","volume":"16","author":"W Jiang","year":"2025","unstructured":"Jiang W, Zeng Q, Liu C-H, Wang Y, Wang S, Chen E, et al. Huc-MSCs-derived exosomes alleviate non-alcoholic steatohepatitis by regulating macrophages polarization through miR-24-3p\/STING axis. Stem Cell Res Ther. 2025;16:74. https:\/\/doi.org\/10.1186\/s13287-025-04197-6.","journal-title":"Stem Cell Res Ther"},{"key":"1520_CR210","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1186\/s13287-022-03010-y","volume":"13","author":"S Tian","year":"2022","unstructured":"Tian S, Zhou X, Zhang M, Cui L, Li B, Liu Y, et al. Mesenchymal stem cell-derived exosomes protect against liver fibrosis via delivering miR-148a to target KLF6\/STAT3 pathway in macrophages. Stem Cell Res Ther. 2022;13:330. https:\/\/doi.org\/10.1186\/s13287-022-03010-y.","journal-title":"Stem Cell Res Ther"},{"key":"1520_CR211","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-023-01942-y","volume":"21","author":"F Cheng","year":"2023","unstructured":"Cheng F, Yang F, Wang Y, Zhou J, Qian H, Yan Y. Mesenchymal stem cell-derived exosomal miR-27b-3p alleviates liver fibrosis via downregulating YAP\/LOXL2 pathway. J Nanobiotechnology. 2023;21:195. https:\/\/doi.org\/10.1186\/s12951-023-01942-y.","journal-title":"J Nanobiotechnology"},{"key":"1520_CR212","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1631\/jzus.B2300305","volume":"25","author":"Y Wang","year":"2024","unstructured":"Wang Y, Chen Y, Yang F, Yu X, Chu Y, Zhou J, et al. MiR-4465-modified mesenchymal stem cell-derived small extracellular vesicles inhibit liver fibrosis development via targeting LOXL2 expression. J Zhejiang Univ Sci B. 2024;25:594\u2013604. https:\/\/doi.org\/10.1631\/jzus.B2300305.","journal-title":"J Zhejiang Univ Sci B"},{"key":"1520_CR213","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-024-05152-4","author":"Z Liu","year":"2024","unstructured":"Liu Z, Jiang X, You H, Tang Z, Ma Y, Che N, et al. Extracellular vesicles derived from bone marrow mesenchymal stem cells ameliorate liver fibrosis via micro-7045-5p. Mol Cell Biochem. 2024. https:\/\/doi.org\/10.1007\/s11010-024-05152-4.","journal-title":"Mol Cell Biochem"},{"key":"1520_CR214","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-025-03291-4","volume":"23","author":"Z Wang","year":"2025","unstructured":"Wang Z, Yuan M, Yao L, Xiong Z, Dai K, Liu P, et al. Exosomal miR-499a-5p from human umbilical cord mesenchymal stem cells attenuates liver fibrosis via targeting ETS1\/GPX4-mediated ferroptosis in hepatic stellate cells. J Nanobiotechnol. 2025;23:222. https:\/\/doi.org\/10.1186\/s12951-025-03291-4.","journal-title":"J Nanobiotechnol"},{"key":"1520_CR215","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1080\/10717544.2022.2030428","volume":"29","author":"L Ma","year":"2022","unstructured":"Ma L, Wei J, Zeng Y, Liu J, Xiao E, Kang Y. Mesenchymal stem cell-originated exosomal circDIDO1 suppresses hepatic stellate cell activation by miR-141-3p\/PTEN\/AKT pathway in human liver fibrosis. Drug Deliv. 2022;29:440\u201353. https:\/\/doi.org\/10.1080\/10717544.2022.2030428.","journal-title":"Drug Deliv"},{"key":"1520_CR216","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/s12276-025-01413-4","volume":"57","author":"J Zhang","year":"2025","unstructured":"Zhang J, Qiu X, Lei Y, Chen H, Wu D, Wang T, et al. Engineered EVs from LncEEF1G - overexpressing MSCs promote fibrotic liver regeneration by upregulating HGF release from hepatic stellate cells. Exp Mol Med. 2025;57:584\u2013600. https:\/\/doi.org\/10.1038\/s12276-025-01413-4.","journal-title":"Exp Mol Med"},{"key":"1520_CR217","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17132186","volume":"17","author":"Y-W Luo","year":"2025","unstructured":"Luo Y-W, Liu C-G, Kirby JA, Chu C, Zang D, Chen J. The emerging role of extracellular vesicle-derived lncRNAs and circRNAs in tumor and mesenchymal stem cells: the biological functions and potential for clinical application. Cancers. 2025;17:2186. https:\/\/doi.org\/10.3390\/cancers17132186.","journal-title":"Cancers"},{"key":"1520_CR218","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10565-022-09714-4","volume":"39","author":"J Ma","year":"2023","unstructured":"Ma J, Li Y, Chen M, Wang W, Zhao Q, He B, et al. hMSCs-derived exosome circCDK13 inhibits liver fibrosis by regulating the expression of MFGE8 through miR-17-5p\/KAT2B. Cell Biol Toxicol. 2023;39:1\u201322. https:\/\/doi.org\/10.1007\/s10565-022-09714-4.","journal-title":"Cell Biol Toxicol"},{"key":"1520_CR219","doi-asserted-by":"publisher","first-page":"171","DOI":"10.2147\/JIR.S439974","volume":"17","author":"L Zhu","year":"2024","unstructured":"Zhu L, Wang Q, Guo M, Fang H, Li T, Zhu Y, et al. Mesenchymal stem cell-derived exosomes in various chronic liver diseases: Hype or hope? J Inflamm Res. 2024;17:171\u201389. https:\/\/doi.org\/10.2147\/JIR.S439974.","journal-title":"J Inflamm Res"},{"key":"1520_CR220","doi-asserted-by":"publisher","first-page":"334","DOI":"10.30476\/ijms.2024.103376.3660","volume":"50","author":"Z Moayedfard","year":"2025","unstructured":"Moayedfard Z, Bagheri Lankarani K, Alizadeh AA, Nekooeian AA, Dara M, Koohpeyma F, et al. The ameliorative effect of adipose-derived mesenchymal stem cells and their exosomes in non-alcoholic steatohepatitis by simultaneously enhancing autophagic flux and suppressing endoplasmic reticulum stress. Iran J Med Sci. 2025;50:334\u201350. https:\/\/doi.org\/10.30476\/ijms.2024.103376.3660.","journal-title":"Iran J Med Sci."},{"key":"1520_CR221","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-023-01788-4","volume":"21","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Shang J, Yang Q, Dai Z, Liang Y, Lai C, et al. Exosomes derived from human adipose mesenchymal stem cells ameliorate hepatic fibrosis by inhibiting PI3K\/Akt\/mTOR pathway and remodeling choline metabolism. J Nanobiotechnology. 2023;21:29. https:\/\/doi.org\/10.1186\/s12951-023-01788-4.","journal-title":"J Nanobiotechnology"},{"key":"1520_CR222","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2023.156386","volume":"172","author":"L Gan","year":"2023","unstructured":"Gan L, Zheng L, Yao L, Lei L, Huang Y, Zeng Z, et al. Exosomes from adipose-derived mesenchymal stem cells improve liver fibrosis by regulating the miR-20a-5p\/TGFBR2 axis to affect the p38 MAPK\/NF-\u03baB pathway. Cytokine. 2023;172:156386\u2013156386. https:\/\/doi.org\/10.1016\/j.cyto.2023.156386.","journal-title":"Cytokine"},{"key":"1520_CR223","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-022-03049-x","volume":"13","author":"B Wu","year":"2022","unstructured":"Wu B, Feng J, Guo J, Wang J, Xiu G, Xu J, et al. ADSCs-derived exosomes ameliorate hepatic fibrosis by suppressing stellate cell activation and remodeling hepatocellular glutamine synthetase-mediated glutamine and ammonia homeostasis. Stem Cell Res Ther. 2022;13:494. https:\/\/doi.org\/10.1186\/s13287-022-03049-x.","journal-title":"Stem Cell Res Ther"},{"key":"1520_CR224","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1111\/jcmm.16119","volume":"25","author":"Z Du","year":"2021","unstructured":"Du Z, Wu T, Liu L, Luo B, Wei C. Extracellular vesicles-derived miR-150-5p secreted by adipose-derived mesenchymal stem cells inhibits CXCL1 expression to attenuate hepatic fibrosis. J Cell Mol Med. 2021;25:701\u201315. https:\/\/doi.org\/10.1111\/jcmm.16119.","journal-title":"J Cell Mol Med"},{"key":"1520_CR225","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.reth.2024.10.005","volume":"26","author":"A Gopal","year":"2024","unstructured":"Gopal A, Gangadaran P, Rajendran RL, Oh JM, Lee HW, Hong CM, et al. Extracellular vesicle mimetics engineered from mesenchymal stem cells and curcumin promote fibrosis regression in a mouse model of thioacetamide-induced liver fibrosis. Regen Ther. 2024;26:911\u201321. https:\/\/doi.org\/10.1016\/j.reth.2024.10.005.","journal-title":"Regen Ther"},{"key":"1520_CR226","doi-asserted-by":"publisher","DOI":"10.3390\/cells11244004","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Zhangdi H, Nie X, Wang L, Wan Z, Jin H, et al. Exosomes derived from BMMSCs mitigate the hepatic fibrosis via anti-pyroptosis pathway in a cirrhosis model. Cells. 2022. https:\/\/doi.org\/10.3390\/cells11244004.","journal-title":"Cells"},{"key":"1520_CR227","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21228874","author":"R Angioni","year":"2020","unstructured":"Angioni R, Cali B, Vigneswara V, Crescenzi M, Merino A, Sanchez-Rodriguez R, et al. Administration of human MSC-derived extracellular vesicles for the treatment of primary sclerosing cholangitis: preclinical data in MDR2 knockout mice. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21228874.","journal-title":"Int J Mol Sci"},{"key":"1520_CR228","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-019-1204-2","volume":"10","author":"X Rong","year":"2019","unstructured":"Rong X, Liu J, Yao X, Jiang T, Wang Y, Xie F. Human bone marrow mesenchymal stem cells-derived exosomes alleviate liver fibrosis through the Wnt\/\u03b2-catenin pathway. Stem Cell Res Ther. 2019;10:98. https:\/\/doi.org\/10.1186\/s13287-019-1204-2.","journal-title":"Stem Cell Res Ther"},{"key":"1520_CR229","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-024-10717-y","author":"R Zong","year":"2024","unstructured":"Zong R, Zheng Y, Yan Y, Sun W, Kong L, Huang Y, et al. Mesenchymal stem cells-derived exosomes alleviate liver fibrosis by targeting Hedgehog\/SMO signaling. Hepatol Int. 2024. https:\/\/doi.org\/10.1007\/s12072-024-10717-y.","journal-title":"Hepatol Int"},{"key":"1520_CR230","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107471","volume":"209","author":"Y Wang","year":"2024","unstructured":"Wang Y, Wang C, Yang F, Chen Y, Shi Y, Xu R, et al. USP9X-enriched MSC-sEV inhibits LSEC angiogenesis in MASH mice by downregulating the I\u03baB\u03b1\/NF-\u03baB\/ang-2 pathway. Pharmacol Res. 2024;209:107471. https:\/\/doi.org\/10.1016\/j.phrs.2024.107471.","journal-title":"Pharmacol Res"},{"key":"1520_CR231","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2023.100746","volume":"5","author":"F Yang","year":"2023","unstructured":"Yang F, Wu Y, Chen Y, Xi J, Chu Y, Jin J, et al. Human umbilical cord mesenchymal stem cell-derived exosomes ameliorate liver steatosis by promoting fatty acid oxidation and reducing fatty acid synthesis. JHEP Rep. 2023;5:100746. https:\/\/doi.org\/10.1016\/j.jhepr.2023.100746.","journal-title":"JHEP Rep"},{"key":"1520_CR232","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04764-2","volume":"13","author":"Y Tan","year":"2022","unstructured":"Tan Y, Huang Y, Mei R, Mao F, Yang D, Liu J, et al. HucMSC-derived exosomes delivered BECN1 induces ferroptosis of hepatic stellate cells via regulating the xCT\/GPX4 axis. Cell Death Dis. 2022;13:319. https:\/\/doi.org\/10.1038\/s41419-022-04764-2.","journal-title":"Cell Death Dis"},{"key":"1520_CR233","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/6079642","volume":"2018","author":"W Jiang","year":"2018","unstructured":"Jiang W, Tan Y, Cai M, Zhao T, Mao F, Zhang X, et al. Human umbilical cord MSC-derived exosomes suppress the development of CCl4-induced liver injury through antioxidant effect. Stem Cells Int. 2018;2018:6079642. https:\/\/doi.org\/10.1155\/2018\/6079642.","journal-title":"Stem Cells Int"},{"key":"1520_CR234","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1089\/scd.2012.0395","volume":"22","author":"T Li","year":"2013","unstructured":"Li T, Yan Y, Wang B, Qian H, Zhang X, Shen L, et al. Exosomes derived from human umbilical cord mesenchymal stem cells alleviate liver fibrosis. Stem Cells Dev. 2013;22:845\u201354. https:\/\/doi.org\/10.1089\/scd.2012.0395.","journal-title":"Stem Cells Dev"},{"key":"1520_CR235","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s13770-024-00631-7","volume":"21","author":"A-L Xu","year":"2024","unstructured":"Xu A-L, Han L, Yan J, Liu D, Wang W. Effects of mesenchymal stem cells-derived extracellular vesicles on inhibition of hepatic fibrosis by delivering miR-200a. Tissue Eng Regen Med. 2024;21:609\u201324. https:\/\/doi.org\/10.1007\/s13770-024-00631-7.","journal-title":"Tissue Eng Regen Med"},{"key":"1520_CR236","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/3212643","volume":"2018","author":"M Ohara","year":"2018","unstructured":"Ohara M, Ohnishi S, Hosono H, Yamamoto K, Yuyama K, Nakamura H, et al. Extracellular vesicles from amnion-derived mesenchymal stem cells ameliorate hepatic inflammation and fibrosis in rats. Stem Cells Int. 2018;2018:1\u201315. https:\/\/doi.org\/10.1155\/2018\/3212643.","journal-title":"Stem Cells Int"},{"key":"1520_CR237","doi-asserted-by":"publisher","first-page":"724","DOI":"10.30476\/ijms.2023.99524.3159","volume":"49","author":"SH Abd-Allah","year":"2024","unstructured":"Abd-Allah SH, Khamis T, Samy W, Alsemeh AE, Abdullah DM, Hussein S. Mesenchymal stem cells and their derived exosomes mitigated hepatic cirrhosis in rats by altering the expression of miR-23b and miR-221. Iran J Med Sci. 2024;49:724\u201340. https:\/\/doi.org\/10.30476\/ijms.2023.99524.3159.","journal-title":"Iran J Med Sci"},{"key":"1520_CR238","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1016\/j.ymthe.2020.12.025","volume":"29","author":"J Kim","year":"2021","unstructured":"Kim J, Lee C, Shin Y, Wang S, Han J, Kim M, et al. sEVs from tonsil-derived mesenchymal stromal cells alleviate activation of hepatic stellate cells and liver fibrosis through miR-486-5p. Mol Ther. 2021;29:1471\u201386. https:\/\/doi.org\/10.1016\/j.ymthe.2020.12.025.","journal-title":"Mol Ther"},{"key":"1520_CR239","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24098092","volume":"24","author":"B Zhang","year":"2023","unstructured":"Zhang B, Zhang B, Lai RC, Sim WK, Lam KP, Lim SK. MSC\u2212sEV treatment polarizes pro\u2212fibrotic M2 macrophages without exacerbating liver fibrosis in NASH. Int J Mol Sci. 2023;24:8092. https:\/\/doi.org\/10.3390\/ijms24098092.","journal-title":"Int J Mol Sci"},{"key":"1520_CR240","doi-asserted-by":"publisher","first-page":"9330","DOI":"10.1002\/jcp.26413","volume":"233","author":"S Mardpour","year":"2018","unstructured":"Mardpour S, Hassani S, Mardpour S, Sayahpour F, Vosough M, Ai J, et al. Extracellular vesicles derived from human embryonic stem cell\u2010MSCs ameliorate cirrhosis in thioacetamide\u2010induced chronic liver injury. J Cell Physiol. 2018;233:9330\u201344. https:\/\/doi.org\/10.1002\/jcp.26413.","journal-title":"J Cell Physiol"},{"key":"1520_CR241","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2024.114325","volume":"443","author":"A Wang","year":"2024","unstructured":"Wang A, Li B, Su W, Zhang H, Hu R, Zhang Y, et al. Exosomes derived from diabetic microenvironment-preconditioned mesenchymal stem cells ameliorate nonalcoholic fatty liver disease and inhibit pyroptosis of hepatocytes. Exp Cell Res. 2024;443:114325. https:\/\/doi.org\/10.1016\/j.yexcr.2024.114325.","journal-title":"Exp Cell Res"},{"key":"1520_CR242","doi-asserted-by":"publisher","DOI":"10.1016\/j.trim.2023.101837","volume":"78","author":"GA-E Tawfeek","year":"2023","unstructured":"Tawfeek GA-E, Kasem HA. Curcumin preconditioned mesenchymal stem cells derived exosomes transplantation ameliorate and protect against non- alcoholic steatohepatitis by regulation the expression of key genes of inflammation and oxidative stress. Transpl Immunol. 2023;78:101837. https:\/\/doi.org\/10.1016\/j.trim.2023.101837.","journal-title":"Transpl Immunol"},{"key":"1520_CR243","doi-asserted-by":"publisher","DOI":"10.1038\/s41536-021-00132-4","volume":"6","author":"S Takeuchi","year":"2021","unstructured":"Takeuchi S, Tsuchiya A, Iwasawa T, Nojiri S, Watanabe T, Ogawa M, et al. Small extracellular vesicles derived from interferon-\u03b3 pre-conditioned mesenchymal stromal cells effectively treat liver fibrosis. NPJ Regen Med. 2021;6:19. https:\/\/doi.org\/10.1038\/s41536-021-00132-4.","journal-title":"NPJ Regen Med"},{"key":"1520_CR244","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202309940","volume":"11","author":"Y Xu","year":"2024","unstructured":"Xu Y, Zhang Y, Tian H, Zhong Q, Yi K, Li F, et al. Smart microneedle arrays integrating cell-free therapy and nanocatalysis to treat liver fibrosis. Adv Sci. 2024;11:2309940. https:\/\/doi.org\/10.1002\/advs.202309940.","journal-title":"Adv Sci"},{"key":"1520_CR245","doi-asserted-by":"publisher","first-page":"17948","DOI":"10.1021\/acsami.4c19748","volume":"17","author":"Z Wang","year":"2025","unstructured":"Wang Z, Zhong D, Yan T, Zheng Q, Zhou E, Ye Z, et al. Stem cells from human exfoliated deciduous teeth-derived exosomes for the treatment of acute liver injury and liver fibrosis. ACS Appl Mater Interfaces. 2025;17:17948\u201364. https:\/\/doi.org\/10.1021\/acsami.4c19748.","journal-title":"ACS Appl Mater Interfaces"},{"key":"1520_CR246","doi-asserted-by":"publisher","first-page":"244","DOI":"10.34133\/bmr.0244","volume":"29","author":"S Tian","year":"2025","unstructured":"Tian S, Zhou X, Zheng L, Liu J, Zhang M, Ma S, et al. Engineered mesenchymal stem cell-derived small extracellular vesicles mitigate liver fibrosis by delivering USP10 to reprogram macrophage phenotype. Biomater Res. 2025;29:244. https:\/\/doi.org\/10.34133\/bmr.0244.","journal-title":"Biomater Res."},{"key":"1520_CR247","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2025.123140","volume":"318","author":"T Saha","year":"2025","unstructured":"Saha T, Mehrotra S, Gupta P, Kumar A. Exosomal miRNA combined with anti-inflammatory hyaluronic acid-based 3D bioprinted hepatic patch promotes metabolic reprogramming in NAFLD-mediated fibrosis. Biomaterials. 2025;318:123140. https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123140.","journal-title":"Biomaterials"},{"key":"1520_CR248","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2025.123429","volume":"364","author":"G Mincheva","year":"2025","unstructured":"Mincheva G, Moreno-Manzano V, Felipo V, Llansola M. Extracellular vesicles from mesenchymal stem cells improve liver injury in rats with mild liver damage. Underlying mechanisms and role of TGF\u03b2. Life Sci. 2025;364:123429. https:\/\/doi.org\/10.1016\/j.lfs.2025.123429.","journal-title":"Life Sci"},{"key":"1520_CR249","doi-asserted-by":"publisher","first-page":"3475","DOI":"10.2147\/IJN.S450284","volume":"19","author":"D Zhu","year":"2024","unstructured":"Zhu D, Sun Z, Wei J, Zhang Y, An W, Lin Y, et al. BMP7-loaded human umbilical cord mesenchymal stem cell-derived small extracellular vesicles ameliorate liver fibrosis by targeting activated hepatic stellate cells. Int J Nanomedicine. 2024;19:3475\u201395. https:\/\/doi.org\/10.2147\/IJN.S450284.","journal-title":"Int J Nanomedicine"},{"key":"1520_CR250","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jconrel.2024.09.046","volume":"376","author":"J-H Xing","year":"2024","unstructured":"Xing J-H, Hou L-S, Zhang K, Zhang Y-W, Zheng C, Cai Z, et al. Microenvironment-responsive nano-bioconjugated vesicles for the multi-pronged treatment of liver fibrosis. J Control Release. 2024;376:52\u201366. https:\/\/doi.org\/10.1016\/j.jconrel.2024.09.046.","journal-title":"J Control Release"},{"key":"1520_CR251","doi-asserted-by":"publisher","DOI":"10.14670\/HH-18-816","author":"H Zhou","year":"2024","unstructured":"Zhou H, Wu Y, Xue J, Yu L. Ameliorative effects of HGF-overexpressed exosomes derived from ADMSCs on oxidative stress in hepatic fibrosis. Histol Histopathol. 2024. https:\/\/doi.org\/10.14670\/HH-18-816.","journal-title":"Histol Histopathol"},{"key":"1520_CR252","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s10616-023-00611-0","volume":"76","author":"J Wang","year":"2024","unstructured":"Wang J, Ye W, Jiang M, Zhou Y, Zheng J. Therapeutic potential of exosome derived from hepatocyte growth factor-overexpressing adipose mesenchymal stem cells in TGF\u03b21-stimulated hepatic stellate cells. Cytotechnology. 2024;76:217\u201329. https:\/\/doi.org\/10.1007\/s10616-023-00611-0.","journal-title":"Cytotechnology"},{"key":"1520_CR253","doi-asserted-by":"publisher","DOI":"10.5603\/fhc.95291","author":"L Yu","year":"2023","unstructured":"Yu L, Xue J, Wu Y, Zhou H. Therapeutic effect of exosomes derived from hepatocyte-growth-factor-overexpressing adipose mesenchymal stem cells on liver injury. Folia Histochem Cytobiol. 2023. https:\/\/doi.org\/10.5603\/fhc.95291.","journal-title":"Folia Histochem Cytobiol"},{"key":"1520_CR254","doi-asserted-by":"publisher","first-page":"50863","DOI":"10.1021\/acsami.3c11046","volume":"15","author":"Y-W Zhang","year":"2023","unstructured":"Zhang Y-W, Hou L-S, Xing J-H, Zhang T-R, Zhou S-Y, Zhang B-L. Two-membrane hybrid nanobiomimetic delivery system for targeted autophagy inhibition of activated hepatic stellate cells to synergistically treat liver fibrosis. ACS Appl Mater Interfaces. 2023;15:50863\u201377. https:\/\/doi.org\/10.1021\/acsami.3c11046.","journal-title":"ACS Appl Mater Interfaces"},{"key":"1520_CR255","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24119586","volume":"24","author":"LMM Dominguez","year":"2023","unstructured":"Dominguez LMM, Bueloni B, Cantero MJ, Albornoz M, Pacienza N, Biani C, et al. Chromatographic scalable method to isolate engineered extracellular vesicles derived from mesenchymal stem cells for the treatment of liver fibrosis in mice. Int J Mol Sci. 2023;24:9586. https:\/\/doi.org\/10.3390\/ijms24119586.","journal-title":"Int J Mol Sci"},{"key":"1520_CR256","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-022-01636-x","volume":"20","author":"Y Lin","year":"2022","unstructured":"Lin Y, Yan M, Bai Z, Xie Y, Ren L, Wei J, et al. Huc-MSC-derived exosomes modified with the targeting peptide of aHSCs for liver fibrosis therapy. J Nanobiotechnol. 2022;20:432. https:\/\/doi.org\/10.1186\/s12951-022-01636-x.","journal-title":"J Nanobiotechnol"},{"key":"1520_CR257","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.jconrel.2021.06.031","volume":"336","author":"DG You","year":"2021","unstructured":"You DG, Oh BH, Nguyen VQ, Lim GT, Um W, Jung JM, et al. Vitamin A-coupled stem cell-derived extracellular vesicles regulate the fibrotic cascade by targeting activated hepatic stellate cells in vivo. J Control Release. 2021;336:285\u201395. https:\/\/doi.org\/10.1016\/j.jconrel.2021.06.031.","journal-title":"J Control Release"},{"key":"1520_CR258","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202002777RR","volume":"35","author":"M Tang","year":"2021","unstructured":"Tang M, Chen Y, Li B, Sugimoto H, Yang S, Yang C, et al. Therapeutic targeting of STAT3 with small interference RNAs and antisense oligonucleotides embedded exosomes in liver fibrosis. FASEB J. 2021;35:e21557. https:\/\/doi.org\/10.1096\/fj.202002777RR.","journal-title":"FASEB J"},{"key":"1520_CR259","doi-asserted-by":"publisher","first-page":"37421","DOI":"10.1021\/acsami.9b10126","volume":"11","author":"S Mardpour","year":"2019","unstructured":"Mardpour S, Ghanian MH, Sadeghi-Abandansari H, Mardpour S, Nazari A, Shekari F, et al. Hydrogel-mediated sustained systemic delivery of mesenchymal stem cell-derived extracellular vesicles improves hepatic regeneration in chronic liver failure. ACS Appl Mater Interfaces. 2019;11:37421\u201333. https:\/\/doi.org\/10.1021\/acsami.9b10126.","journal-title":"ACS Appl Mater Interfaces"},{"key":"1520_CR260","doi-asserted-by":"publisher","DOI":"10.1515\/med-2024-0945","volume":"19","author":"Y Cao","year":"2024","unstructured":"Cao Y, Yang H, Huang Y, Lu J, Du H, Wang B. Mesenchymal stem cell-derived exosomal miR-26a induces ferroptosis, suppresses hepatic stellate cell activation, and ameliorates liver fibrosis by modulating SLC7A11. Open Med (wars Pol). 2024;19:20240945. https:\/\/doi.org\/10.1515\/med-2024-0945.","journal-title":"Open Med (wars Pol)"},{"key":"1520_CR261","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110294","author":"B Niknam","year":"2023","unstructured":"Niknam B, Baghaei K, Hashemi SM, Hatami B, Zali MR, Amani D. Human Wharton\u2019s jelly mesenchymal stem cells derived-exosomes enriched by miR-124 promote an anti-fibrotic response in an experimental model of liver fibrosis. Int Immunopharmacol. 2023. https:\/\/doi.org\/10.1016\/j.intimp.2023.110294.","journal-title":"Int Immunopharmacol"},{"key":"1520_CR262","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s12033-021-00441-5","volume":"64","author":"J Xuan","year":"2022","unstructured":"Xuan J, Xu H, Li H, Chen D, Qiu Y, Chen X, et al. Extracellular vesicles from miR-148a-5p-enriched bone marrow mesenchymal stem cells relieve hepatic fibrosis by targeting Smad4. Mol Biotechnol. 2022;64:535\u201345. https:\/\/doi.org\/10.1007\/s12033-021-00441-5.","journal-title":"Mol Biotechnol"},{"key":"1520_CR263","doi-asserted-by":"publisher","first-page":"5915","DOI":"10.1080\/21655979.2021.2023799","volume":"13","author":"C Sun","year":"2022","unstructured":"Sun C, Shi C, Duan X, Zhang Y, Wang B. Exosomal microRNA-618 derived from mesenchymal stem cells attenuate the progression of hepatic fibrosis by targeting Smad4. Bioengineered. 2022;13:5915\u201327. https:\/\/doi.org\/10.1080\/21655979.2021.2023799.","journal-title":"Bioengineered"},{"key":"1520_CR264","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.molimm.2017.11.008","volume":"93","author":"L Chen","year":"2018","unstructured":"Chen L, Lu F-B, Chen D-Z, Wu J-L, Hu E, Xu L-M, et al. BMSCs-derived miR-223-containing exosomes contribute to liver protection in experimental autoimmune hepatitis. Mol Immunol. 2018;93:38\u201346. https:\/\/doi.org\/10.1016\/j.molimm.2017.11.008.","journal-title":"Mol Immunol"},{"key":"1520_CR265","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1111\/jcmm.13170","volume":"21","author":"Y Qu","year":"2017","unstructured":"Qu Y, Zhang Q, Cai X, Li F, Ma Z, Xu M, et al. Exosomes derived from miR-181-5p-modified adipose-derived mesenchymal stem cells prevent liver fibrosis via autophagy activation. J Cell Mol Med. 2017;21:2491\u2013502. https:\/\/doi.org\/10.1111\/jcmm.13170.","journal-title":"J Cell Mol Med"},{"key":"1520_CR266","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115777","volume":"168","author":"A Azizsoltani","year":"2023","unstructured":"Azizsoltani A, Hatami B, Zali MR, Mahdavi V, Baghaei K, Alizadeh E. Obeticholic acid-loaded exosomes attenuate liver fibrosis through dual targeting of the FXR signaling pathway and ECM remodeling. Biomed Pharmacother. 2023;168:115777. https:\/\/doi.org\/10.1016\/j.biopha.2023.115777.","journal-title":"Biomed Pharmacother"},{"key":"1520_CR267","doi-asserted-by":"publisher","first-page":"3270","DOI":"10.1080\/10717544.2022.2142700","volume":"29","author":"AA Ashour","year":"2022","unstructured":"Ashour AA, El-Kamel AH, Mehanna RA, Mourad G, Heikal LA. Luteolin-loaded exosomes derived from bone marrow mesenchymal stem cells: a promising therapy for liver fibrosis. Drug Deliv. 2022;29:3270\u201380. https:\/\/doi.org\/10.1080\/10717544.2022.2142700.","journal-title":"Drug Deliv"},{"key":"1520_CR268","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.121710","volume":"324","author":"MA Didamoony","year":"2023","unstructured":"Didamoony MA, Atwa AM, Ahmed LA. Modulatory effect of rupatadine on mesenchymal stem cell-derived exosomes in hepatic fibrosis in rats: a potential role for miR-200a. Life Sci. 2023;324:121710. https:\/\/doi.org\/10.1016\/j.lfs.2023.121710.","journal-title":"Life Sci"},{"key":"1520_CR269","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2023.2184150","author":"C Deng","year":"2023","unstructured":"Deng C, Hu J, He L, Ge L, Wu N, Xie M, et al. Daucosterol combined with umbilical cord mesenchymal stem cell-derived exosomes can alleviate liver damage in liver failure mice by regulating the IL-6\/STAT3 signaling pathway. Cancer Biol Ther. 2023. https:\/\/doi.org\/10.1080\/15384047.2023.2184150.","journal-title":"Cancer Biol Ther"},{"key":"1520_CR270","unstructured":"Search for: liver cirrhosis OR liver fibrosis, cell | list results | ClinicalTrials.gov [Internet]. [cited 2025 Jan 2]. Accessed 2 Jan 2025."},{"key":"1520_CR271","doi-asserted-by":"publisher","first-page":"7264","DOI":"10.3748\/wjg.v21.i23.7264","volume":"21","author":"M Sharma","year":"2015","unstructured":"Sharma M, Rao PN, Sasikala M, Kuncharam MR, Reddy C, Gokak V, et al. Autologous mobilized peripheral blood CD34+ cell infusion in non-viral decompensated liver cirrhosis. World J Gastroentero. 2015;21:7264\u201371. https:\/\/doi.org\/10.3748\/wjg.v21.i23.7264.","journal-title":"World J Gastroentero"},{"key":"1520_CR272","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.dld.2015.08.018","volume":"47","author":"P Andreone","year":"2015","unstructured":"Andreone P, Catani L, Margini C, Brodosi L, Lorenzini S, Sollazzo D, et al. Reinfusion of highly purified CD133+ bone marrow-derived stem\/progenitor cells in patients with end-stage liver disease: a phase I clinical trial. Dig Liver Dis. 2015;47:1059\u201366. https:\/\/doi.org\/10.1016\/j.dld.2015.08.018.","journal-title":"Dig Liver Dis"},{"key":"1520_CR273","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.3727\/096368910X514314","volume":"19","author":"H Salama","year":"2010","unstructured":"Salama H, Zekri A-R, Zern M, Bahnassy A, Loutfy S, Shalaby S, et al. Autologous hematopoietic stem cell transplantation in 48 patients with end-stage chronic liver diseases. Cell Transplant. 2010;19:1475\u201386. https:\/\/doi.org\/10.3727\/096368910X514314.","journal-title":"Cell Transplant"},{"key":"1520_CR274","doi-asserted-by":"publisher","first-page":"5297","DOI":"10.3748\/wjg.v16.i42.5297","volume":"16","author":"H Salama","year":"2010","unstructured":"Salama H, Zekri A-RN, Bahnassy AA, Medhat E, Halim HA, Ahmed OS, et al. Autologous CD34+ and CD133+ stem cells transplantation in patients with end stage liver disease. World J Gastroenterol. 2010;16:5297\u2013305. https:\/\/doi.org\/10.3748\/wjg.v16.i42.5297.","journal-title":"World J Gastroenterol"},{"key":"1520_CR275","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1111\/j.1572-0241.2008.01993.x","volume":"103","author":"M Pai","year":"2008","unstructured":"Pai M, Zacharoulis D, Milicevic MN, Helmy S, Jiao LR, Levi\u010dar N, et al. Autologous infusion of expanded mobilized adult bone marrow-derived CD34+ cells into patients with alcoholic liver cirrhosis. Am J Gastroenterol. 2008;103:1952\u20138. https:\/\/doi.org\/10.1111\/j.1572-0241.2008.01993.x.","journal-title":"Am J Gastroenterol"},{"key":"1520_CR276","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/j.1365-2184.2008.00491.x","volume":"41","author":"N Levi\u010dar","year":"2008","unstructured":"Levi\u010dar N, Pai M, Habib NA, Tait P, Jiao LR, Marley SB, et al. Long-term clinical results of autologous infusion of mobilized adult bone marrow derived CD34 + cells in patients with chronic liver disease. Cell Prolif. 2008;41:115\u201325. https:\/\/doi.org\/10.1111\/j.1365-2184.2008.00491.x.","journal-title":"Cell Prolif"},{"key":"1520_CR277","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1016\/j.transproceed.2008.03.111","volume":"40","author":"AA Khan","year":"2008","unstructured":"Khan AA, Parveen N, Mahaboob VS, Rajendraprasad A, Ravindraprakash HR, Venkateswarlu J, et al. Safety and efficacy of autologous bone marrow stem cell transplantation through hepatic artery for the treatment of chronic liver failure: a preliminary study. Transplant Proc. 2008;40:1140\u20134. https:\/\/doi.org\/10.1016\/j.transproceed.2008.03.111.","journal-title":"Transplant Proc"},{"key":"1520_CR278","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1089\/scd.2011.0074","volume":"20","author":"T Saito","year":"2011","unstructured":"Saito T, Okumoto K, Haga H, Nishise Y, Ishii R, Sato C, et al. Potential therapeutic application of intravenous autologous bone marrow infusion in patients with alcoholic liver cirrhosis. Stem Cells Dev. 2011;20:1503\u201310. https:\/\/doi.org\/10.1089\/scd.2011.0074.","journal-title":"Stem Cells Dev"},{"key":"1520_CR279","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/j.1478-3231.2010.02424.x","volume":"31","author":"BG Couto","year":"2011","unstructured":"Couto BG, dos Santos Goldenberg RC, da Fonseca LMB, Thomas J, Gutfilen B, Resende CMC, et al. Bone marrow mononuclear cell therapy for patients with cirrhosis: a phase 1 study. Liver Int. 2011;31:391\u2013400. https:\/\/doi.org\/10.1111\/j.1478-3231.2010.02424.x.","journal-title":"Liver Int"},{"key":"1520_CR280","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1097\/MEG.0b013e32832eb69a","volume":"22","author":"AC Lyra","year":"2010","unstructured":"Lyra AC, Soares MBP, da Silva LFM, Braga EL, Oliveira SA, Fortes MF, et al. Infusion of autologous bone marrow mononuclear cells through hepatic artery results in a short-term improvement of liver function in patients with chronic liver disease: a pilot randomized controlled study. Eur J Gastroenterol Hepatol. 2010;22:33\u201342. https:\/\/doi.org\/10.1097\/MEG.0b013e32832eb69a.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1520_CR281","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.3727\/096368910X506863","volume":"19","author":"JK Kim","year":"2010","unstructured":"Kim JK, Park YN, Kim JS, Park M-S, Paik YH, Seok J-Y, et al. Autologous bone marrow infusion activates the progenitor cell compartment in patients with advanced liver cirrhosis. Cell Transplant. 2010;19:1237\u201346. https:\/\/doi.org\/10.3727\/096368910X506863.","journal-title":"Cell Transplant"},{"key":"1520_CR282","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1080\/14653240802129901","volume":"10","author":"Y Han","year":"2008","unstructured":"Han Y, Yan L, Han G, Zhou X, Hong L, Yin Z, et al. Controlled trials in hepatitis B virus-related decompensate liver cirrhosis: peripheral blood monocyte transplant versus granulocyte\u2013colony-stimulating factor mobilization therapy. Cytotherapy. 2008;10:390\u20136. https:\/\/doi.org\/10.1080\/14653240802129901.","journal-title":"Cytotherapy"},{"key":"1520_CR283","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1002\/ajh.21030","volume":"82","author":"L Yan","year":"2007","unstructured":"Yan L, Han Y, Wang J, Liu J, Hong L, Fan D. Peripheral blood monocytes from patients with HBV related decompensated liver cirrhosis can differentiate into functional hepatocytes. Am J Hematol. 2007;82:949\u201354. https:\/\/doi.org\/10.1002\/ajh.21030.","journal-title":"Am J Hematol"},{"key":"1520_CR284","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.3748\/wjg.v13.i7.1067","volume":"13","author":"AC Lyra","year":"2007","unstructured":"Lyra AC, Soares MB, da Silva LF, Fortes MF, Silva AG, de Andrade Mota AC, et al. Feasibility and safety of autologous bone marrow mononuclear cell transplantation in patients with advanced chronic liver disease. World J Gastroentero. 2007;13:1067\u201373. https:\/\/doi.org\/10.3748\/wjg.v13.i7.1067.","journal-title":"World J Gastroentero"},{"key":"1520_CR285","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1007\/s11605-022-05528-1","volume":"27","author":"Z Li","year":"2023","unstructured":"Li Z, Zhou X, Han L, Shi M, Xiao H, Lin M, et al. Human umbilical cord blood-derived mesenchymal stem cell transplantation for patients with decompensated liver cirrhosis. J Gastrointest Surg. 2023;27:926\u201331. https:\/\/doi.org\/10.1007\/s11605-022-05528-1.","journal-title":"J Gastrointest Surg"},{"key":"1520_CR286","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jceh.2021.03.010","volume":"12","author":"M Sharma","year":"2022","unstructured":"Sharma M, Pondugala PK, Jaggaihgari S, Mitnala S, Krishna VV, Jaishetwar G, et al. Safety assessment of autologous stem cell combination therapy in patients with decompensated liver cirrhosis: a pilot study. J Clin Exp Hepatol. 2022;12:80\u20138. https:\/\/doi.org\/10.1016\/j.jceh.2021.03.010.","journal-title":"J Clin Exp Hepatol"},{"key":"1520_CR287","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1007\/s12072-021-10199-2","volume":"15","author":"M Shi","year":"2021","unstructured":"Shi M, Li Y-Y, Xu R-N, Meng F-P, Yu S-J, Fu J-L, et al. Mesenchymal stem cell therapy in decompensated liver cirrhosis: a long-term follow-up analysis of the randomized controlled clinical trial. Hepatol Int. 2021;15:1431\u201341. https:\/\/doi.org\/10.1007\/s12072-021-10199-2.","journal-title":"Hepatol Int"},{"key":"1520_CR288","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1111\/jgh.14081","volume":"33","author":"X Fang","year":"2018","unstructured":"Fang X, Liu L, Dong J, Zhang J, Song H, Song Y, et al. A study about immunomodulatory effect and efficacy and prognosis of human umbilical cord mesenchymal stem cells in patients with chronic hepatitis B-induced decompensated liver cirrhosis. J Gastroenterol Hepatol. 2018;33:774\u201380. https:\/\/doi.org\/10.1111\/jgh.14081.","journal-title":"J Gastroenterol Hepatol"},{"key":"1520_CR289","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1111\/1756-185X.13015","volume":"20","author":"J Liang","year":"2017","unstructured":"Liang J, Zhang H, Zhao C, Wang D, Ma X, Zhao S, et al. Effects of allogeneic mesenchymal stem cell transplantation in the treatment of liver cirrhosis caused by autoimmune diseases. Int J Rheum Dis. 2017;20:1219\u201326. https:\/\/doi.org\/10.1111\/1756-185X.13015.","journal-title":"Int J Rheum Dis"},{"key":"1520_CR290","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jhep.2017.03.001","volume":"67","author":"O Detry","year":"2017","unstructured":"Detry O, Vandermeulen M, Delbouille M-H, Somja J, Bletard N, Briquet A, et al. Infusion of mesenchymal stromal cells after deceased liver transplantation: a phase I-II, open-label, clinical study. J Hepatol. 2017;67:47\u201355. https:\/\/doi.org\/10.1016\/j.jhep.2017.03.001.","journal-title":"J Hepatol"},{"key":"1520_CR291","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.reth.2016.12.001","volume":"6","author":"Y Sakai","year":"2017","unstructured":"Sakai Y, Takamura M, Seki A, Sunagozaka H, Terashima T, Komura T, et al. Phase I clinical study of liver regenerative therapy for cirrhosis by intrahepatic arterial infusion of freshly isolated autologous adipose tissue-derived stromal\/stem (regenerative) cell. Regen Ther. 2017;6:52\u201364. https:\/\/doi.org\/10.1016\/j.reth.2016.12.001.","journal-title":"Regen Ther"},{"key":"1520_CR292","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1002\/hep.28693","volume":"64","author":"KT Suk","year":"2016","unstructured":"Suk KT, Yoon J, Kim MY, Kim CW, Kim JK, Park H, et al. Transplantation with autologous bone marrow\u2010derived mesenchymal stem cells for alcoholic cirrhosis: phase 2 trial. Hepatology. 2016;64:2185\u201397. https:\/\/doi.org\/10.1002\/hep.28693.","journal-title":"Hepatology"},{"key":"1520_CR293","doi-asserted-by":"publisher","first-page":"244","DOI":"10.5152\/tjg.2015.0074","volume":"26","author":"M Kantarcioglu","year":"2015","unstructured":"Kantarcioglu M, Demirci H, Avcu F, Karslioglu Y, Babayigit MA, Karaman B, et al. Efficacy of autologous mesenchymal stem cell transplantation in patients with liver cirrhosis. Turk J Gastroenterol. 2015;26:244\u201350. https:\/\/doi.org\/10.5152\/tjg.2015.0074.","journal-title":"Turk J Gastroenterol"},{"key":"1520_CR294","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/liv.12218","volume":"34","author":"YO Jang","year":"2014","unstructured":"Jang YO, Kim YJ, Baik SK, Kim MY, Eom YW, Cho MY, et al. Histological improvement following administration of autologous bone marrow\u2010derived mesenchymal stem cells for alcoholic cirrhosis: a pilot study. Liver Int. 2014;34:33\u201341. https:\/\/doi.org\/10.1111\/liv.12218.","journal-title":"Liver Int"},{"key":"1520_CR295","doi-asserted-by":"publisher","DOI":"10.1186\/scrt459","volume":"5","author":"H Salama","year":"2014","unstructured":"Salama H, Zekri A-RN, Medhat E, Al Alim SA, Ahmed OS, Bahnassy AA, et al. Peripheral vein infusion of autologous mesenchymal stem cells in Egyptian HCV-positive patients with end-stage liver disease. Stem Cell Res Ther. 2014;5:70. https:\/\/doi.org\/10.1186\/scrt459.","journal-title":"Stem Cell Res Ther"},{"key":"1520_CR296","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1089\/scd.2013.0500","volume":"23","author":"L Wang","year":"2014","unstructured":"Wang L, Han Q, Chen H, Wang K, Shan G, Kong F, et al. Allogeneic bone marrow mesenchymal stem cell transplantation in patients with UDCA-resistant primary biliary cirrhosis. Stem Cells Dev. 2014;23:2482. https:\/\/doi.org\/10.1089\/scd.2013.0500.","journal-title":"Stem Cells Dev"},{"key":"1520_CR297","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1111\/jgh.12653","volume":"29","author":"L Xu","year":"2014","unstructured":"Xu L, Gong Y, Wang B, Shi K, Hou Y, Wang L, et al. Randomized trial of autologous bone marrow mesenchymal stem cells transplantation for hepatitis B virus cirrhosis: regulation of Treg\/Th17 cells. J Gastroenterol Hepatol. 2014;29:1620\u20138. https:\/\/doi.org\/10.1111\/jgh.12653.","journal-title":"J Gastroenterol Hepatol"},{"key":"1520_CR298","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1111\/liv.12228","volume":"33","author":"M Mohamadnejad","year":"2013","unstructured":"Mohamadnejad M, Alimoghaddam K, Bagheri M, Ashrafi M, Abdollahzadeh L, Akhlaghpoor S, et al. Randomized placebo-controlled trial of mesenchymal stem cell transplantation in decompensated cirrhosis. Liver Int. 2013;33:1490\u20136. https:\/\/doi.org\/10.1111\/liv.12228.","journal-title":"Liver Int"},{"key":"1520_CR299","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/ctr.12179","volume":"27","author":"MA Amin","year":"2013","unstructured":"Amin MA, Sabry D, Rashed LA, Aref WM, el-Ghobary MA, Farhan MS, et al. Short-term evaluation of autologous transplantation of bone marrow-derived mesenchymal stem cells in patients with cirrhosis: Egyptian study. Clin Transplant. 2013;27:607\u201312. https:\/\/doi.org\/10.1111\/ctr.12179.","journal-title":"Clin Transplant"},{"key":"1520_CR300","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/j.1440-1746.2011.07024.x","volume":"27","author":"Z Zhang","year":"2012","unstructured":"Zhang Z, Lin H, Shi M, Xu R, Fu J, Lv J, et al. Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients. J of Gastro and Hepatol. 2012;27:112\u201320. https:\/\/doi.org\/10.1111\/j.1440-1746.2011.07024.x.","journal-title":"J of Gastro and Hepatol"},{"key":"1520_CR301","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1007\/s12015-011-9322-y","volume":"8","author":"M El-Ansary","year":"2012","unstructured":"El-Ansary M, Abdel-Aziz I, Mogawer S, Abdel-Hamid S, Hammam O, Teaema S, et al. Phase II trial: undifferentiated versus differentiated autologous mesenchymal stem cells transplantation in Egyptian patients with HCV induced liver cirrhosis. Stem Cell Rev Rep. 2012;8:972\u201381. https:\/\/doi.org\/10.1007\/s12015-011-9322-y.","journal-title":"Stem Cell Rev Rep"},{"key":"1520_CR302","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1002\/hep.24434","volume":"54","author":"L Peng","year":"2011","unstructured":"Peng L, Xie D, Lin B-L, Liu J, Zhu H, Xie C, et al. Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: short-term and long-term outcomes. Hepatology. 2011;54:820. https:\/\/doi.org\/10.1002\/hep.24434.","journal-title":"Hepatology"},{"key":"1520_CR303","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1097\/MEG.0b013e3283488b00","volume":"23","author":"M-EM Amer","year":"2011","unstructured":"Amer M-EM, El-Sayed SZ, El-Kheir WA, Gabr H, Gomaa AA, El-Noomani N, et al. Clinical and laboratory evaluation of patients with end-stage liver cell failure injected with bone marrow-derived hepatocyte-like cells. Eur J Gastroenterol Hepatol. 2011;23:936\u201341. https:\/\/doi.org\/10.1097\/MEG.0b013e3283488b00.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1520_CR304","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1097\/MEG.0b013e32832a1f6c","volume":"21","author":"P Kharaziha","year":"2009","unstructured":"Kharaziha P, Hellstr\u00f6m PM, Noorinayer B, Farzaneh F, Aghajani K, Jafari F, et al. Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I-II clinical trial. Eur J Gastroen Hepat. 2009;21:1199\u2013205. https:\/\/doi.org\/10.1097\/MEG.0b013e32832a1f6c.","journal-title":"Eur J Gastroen Hepat"},{"key":"1520_CR305","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-023-03518-x","volume":"14","author":"W Lu","year":"2023","unstructured":"Lu W, Qu J, Yan L, Tang X, Wang X, Ye A, et al. Efficacy and safety of mesenchymal stem cell therapy in liver cirrhosis: a systematic review and meta-analysis. Stem Cell Res Ther. 2023;14:301. https:\/\/doi.org\/10.1186\/s13287-023-03518-x.","journal-title":"Stem Cell Res Ther"},{"key":"1520_CR306","doi-asserted-by":"publisher","unstructured":"Elberry DA, Amin SN, Esmail RSEN, Rashed LA, Gamal MM. Effect of undifferentiated versus hepatogenic partially differentiated mesenchymal stem cells on hepatic and cognitive functions in liver cirrhosis. EXCLI Journal; 15:Doc652; ISSN 1611\u20132156 [Internet]. IfADo - Leibniz Research Centre for Working Environment and Human Factors, Dortmund; 2016 [cited 2023 Sept 19]; https:\/\/doi.org\/10.17179\/EXCLI2016-645","DOI":"10.17179\/EXCLI2016-645"},{"key":"1520_CR307","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1136\/gut.2008.154880","volume":"58","author":"H Aurich","year":"2009","unstructured":"Aurich H, Sgodda M, Kaltwasser P, Vetter M, Weise A, Liehr T, et al. Hepatocyte differentiation of mesenchymal stem cells from human adipose tissue in vitro promotes hepatic integration in vivo. Gut. 2009;58:570\u201381. https:\/\/doi.org\/10.1136\/gut.2008.154880.","journal-title":"Gut"},{"key":"1520_CR308","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1634\/stemcells.2006-0709","volume":"25","author":"D Baksh","year":"2007","unstructured":"Baksh D, Yao R, Tuan RS. Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells. 2007;25:1384\u201392. https:\/\/doi.org\/10.1634\/stemcells.2006-0709.","journal-title":"Stem Cells"},{"key":"1520_CR309","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aba6884","volume":"6","author":"O Levy","year":"2020","unstructured":"Levy O, Kuai R, Siren EMJ, Bhere D, Milton Y, Nissar N, et al. Shattering barriers toward clinically meaningful MSC therapies. Sci Adv. 2020;6:eaba6884. https:\/\/doi.org\/10.1126\/sciadv.aba6884.","journal-title":"Sci Adv"},{"key":"1520_CR310","doi-asserted-by":"publisher","first-page":"455","DOI":"10.5966\/sctm.2012-0184","volume":"2","author":"SM Melief","year":"2013","unstructured":"Melief SM, Zwaginga JJ, Fibbe WE, Roelofs H. Adipose tissue-derived multipotent stromal cells have a higher immunomodulatory capacity than their bone marrow-derived counterparts. Stem Cells Transl Med. 2013;2:455\u201363. https:\/\/doi.org\/10.5966\/sctm.2012-0184.","journal-title":"Stem Cells Transl Med"},{"key":"1520_CR311","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1126\/science.284.5411.143","volume":"284","author":"MF Pittenger","year":"1999","unstructured":"Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143\u20137. https:\/\/doi.org\/10.1126\/science.284.5411.143.","journal-title":"Science"},{"key":"1520_CR312","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s13287-017-0595-1","volume":"8","author":"M Rengasamy","year":"2017","unstructured":"Rengasamy M, Singh G, Fakharuzi NA, Siddikuzzaman, Balasubramanian S, Swamynathan P, et al. Transplantation of human bone marrow mesenchymal stromal cells reduces liver fibrosis more effectively than Wharton\u2019s jelly\u00a0mesenchymal stromal cells. Stem Cell Res Ther. 2017;8:143. https:\/\/doi.org\/10.1186\/s13287-017-0595-1.","journal-title":"Stem Cell Res Ther"},{"key":"1520_CR313","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/1741-7015-11-146","volume":"11","author":"G Siegel","year":"2013","unstructured":"Siegel G, Kluba T, Hermanutz-Klein U, Bieback K, Northoff H, Sch\u00e4fer R. Phenotype, donor age and gender affect function of human bone marrow-derived mesenchymal stromal cells. BMC Med. 2013;11:146. https:\/\/doi.org\/10.1186\/1741-7015-11-146.","journal-title":"BMC Med"},{"key":"1520_CR314","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.918565","volume":"13","author":"ME Fern\u00e1ndez-Santos","year":"2022","unstructured":"Fern\u00e1ndez-Santos ME, Garcia-Arranz M, Andreu EJ, Garc\u00eda-Hern\u00e1ndez AM, L\u00f3pez-Parra M, Villar\u00f3n E, et al. Optimization of mesenchymal stromal cell (MSC) manufacturing processes for a better therapeutic outcome. Front Immunol. 2022;13:918565. https:\/\/doi.org\/10.3389\/fimmu.2022.918565.","journal-title":"Front Immunol"},{"key":"1520_CR315","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/2152435","volume":"2016","author":"M Mar\u0119dziak","year":"2016","unstructured":"Mar\u0119dziak M, Marycz K, Tomaszewski KA, Kornicka K, Henry BM. The influence of aging on the regenerative potential of human adipose derived mesenchymal stem cells. Stem Cells Int. 2016;2016:2152435. https:\/\/doi.org\/10.1155\/2016\/2152435.","journal-title":"Stem Cells Int"},{"key":"1520_CR316","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1007\/s10620-009-0733-4","volume":"55","author":"Y-S Zhong","year":"2010","unstructured":"Zhong Y-S, Lin N, Deng M-H, Zhang F-C, Tang Z-F, Xu R-Y. Deficient proliferation of bone marrow-derived mesenchymal stem cells in patients with chronic hepatitis B viral infections and cirrhosis of the liver. Dig Dis Sci. 2010;55:438\u201345. https:\/\/doi.org\/10.1007\/s10620-009-0733-4.","journal-title":"Dig Dis Sci"},{"key":"1520_CR317","doi-asserted-by":"publisher","first-page":"985","DOI":"10.3324\/haematol.2015.140368","volume":"101","author":"Z Ku\u00e7i","year":"2016","unstructured":"Ku\u00e7i Z, B\u00f6nig H, Kreyenberg H, Bunos M, Jauch A, Janssen JWG, et al. Mesenchymal stromal cells from pooled mononuclear cells of multiple bone marrow donors as rescue therapy in pediatric severe steroid-refractory graft-versus-host disease: a multicenter survey. Haematologica. 2016;101:985\u201394. https:\/\/doi.org\/10.3324\/haematol.2015.140368.","journal-title":"Haematologica"},{"key":"1520_CR318","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.15419\/bmrat.v4i06.179","volume":"4","author":"NH Nguyen","year":"2017","unstructured":"Nguyen NH, Le TV, Do HQ, Ngo DQ, Le HM, Truong NH. Comparative treatment efficiency of adipose and bone marrow derived allogenic mesenchymal stem cell transplantation in mouse models of liver fibrosis. Biomed Res Ther. 2017;4:1374\u201387. https:\/\/doi.org\/10.15419\/bmrat.v4i06.179.","journal-title":"Biomed Res Ther"},{"key":"1520_CR319","doi-asserted-by":"publisher","first-page":"5956","DOI":"10.3892\/etm.2017.5333","volume":"14","author":"T Hao","year":"2017","unstructured":"Hao T, Chen J, Zhi S, Zhang Q, Chen G, Yu F. Comparison of bone marrow-vs. adipose tissue-derived mesenchymal stem cells for attenuating liver fibrosis. Exp Ther Med. 2017;14:5956\u201364. https:\/\/doi.org\/10.3892\/etm.2017.5333.","journal-title":"Exp Ther Med"},{"key":"1520_CR320","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1016\/j.jcyt.2024.07.001","volume":"26","author":"T Mamo","year":"2024","unstructured":"Mamo T, Cox CA, Demorest C, Fontaine MJ, Hubel A, Kelley L, et al. Cryopreservation of mesenchymal stem\/stromal cells using a DMSO-free solution is comparable to DMSO-containing cryoprotectants: results of an international multicenter PACT\/BEST collaborative study. Cytotherapy. 2024;26:1522\u201331. https:\/\/doi.org\/10.1016\/j.jcyt.2024.07.001.","journal-title":"Cytotherapy"},{"key":"1520_CR321","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.1016\/j.ymthe.2018.09.015","volume":"26","author":"RA Haraszti","year":"2018","unstructured":"Haraszti RA, Miller R, Stoppato M, Sere YY, Coles A, Didiot M-C, et al. Exosomes produced from 3D cultures of MSCs by tangential flow filtration show higher yield and improved activity. Mol Ther. 2018;26:2838\u201347. https:\/\/doi.org\/10.1016\/j.ymthe.2018.09.015.","journal-title":"Mol Ther"},{"key":"1520_CR322","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2018.9181","author":"Y Yu","year":"2018","unstructured":"Yu Y, Song Y, Chen Y, Zhang F, Qi F. Differentiation of umbilical cord mesenchymal stem cells into hepatocytes in comparison with bone marrow mesenchymal stem cells. Mol Med Report. 2018. https:\/\/doi.org\/10.3892\/mmr.2018.9181.","journal-title":"Mol Med Report."},{"key":"1520_CR323","doi-asserted-by":"publisher","first-page":"458","DOI":"10.3389\/fcell.2020.00458","volume":"8","author":"DF Stroncek","year":"2020","unstructured":"Stroncek DF, Jin P, McKenna DH, Takanashi M, Fontaine MJ, Pati S, et al. Human mesenchymal stromal cell (MSC) characteristics vary among laboratories when manufactured from the same source material: a report by the cellular therapy team of the biomedical excellence for safer transfusion (BEST) collaborative. Front Cell Dev Biol. 2020;8:458. https:\/\/doi.org\/10.3389\/fcell.2020.00458.","journal-title":"Front Cell Dev Biol"},{"key":"1520_CR324","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1186\/s13287-023-03589-w","volume":"14","author":"JC Fitzgerald","year":"2023","unstructured":"Fitzgerald JC, Shaw G, Murphy JM, Barry F. Media matters: culture medium-dependent hypervariable phenotype of mesenchymal stromal cells. Stem Cell Res Ther. 2023;14:363. https:\/\/doi.org\/10.1186\/s13287-023-03589-w.","journal-title":"Stem Cell Res Ther"},{"key":"1520_CR325","doi-asserted-by":"publisher","DOI":"10.1038\/srep16570","volume":"5","author":"A Oikonomopoulos","year":"2015","unstructured":"Oikonomopoulos A, Van Deen WK, Manansala A-R, Lacey PN, Tomakili TA, Ziman A, et al. Optimization of human mesenchymal stem cell manufacturing: the effects of animal\/xeno-free media. Sci Rep. 2015;5:16570. https:\/\/doi.org\/10.1038\/srep16570.","journal-title":"Sci Rep"},{"key":"1520_CR326","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s13770-020-00306-z","volume":"18","author":"HTH Bui","year":"2021","unstructured":"Bui HTH, Nguyen LT, Than UTT. Influences of xeno-free media on mesenchymal stem cell expansion for clinical application. Tissue Eng Regen Med. 2021;18:15\u201323. https:\/\/doi.org\/10.1007\/s13770-020-00306-z.","journal-title":"Tissue Eng Regen Med"},{"key":"1520_CR327","doi-asserted-by":"publisher","first-page":"300","DOI":"10.3892\/br.2017.845","volume":"6","author":"DS Kim","year":"2017","unstructured":"Kim DS, Lee MW, Lee T-H, Sung KW, Koo HH, Yoo KH. Cell culture density affects the stemness gene expression of adipose tissue-derived mesenchymal stem cells. Biomed Rep. 2017;6:300\u20136. https:\/\/doi.org\/10.3892\/br.2017.845.","journal-title":"Biomed Rep"},{"key":"1520_CR328","doi-asserted-by":"publisher","DOI":"10.3390\/bioengineering10010102","volume":"10","author":"H Nagai","year":"2023","unstructured":"Nagai H, Miwa A, Yoneda K, Fujisawa K, Takami T. Optimizing the seeding density of human mononuclear cells to improve the purity of highly proliferative mesenchymal stem cells. Bioengineering. 2023;10:102. https:\/\/doi.org\/10.3390\/bioengineering10010102.","journal-title":"Bioengineering"},{"key":"1520_CR329","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2121-7-14","volume":"7","author":"MM Bonab","year":"2006","unstructured":"Bonab MM, Alimoghaddam K, Talebian F, Ghaffari SH, Ghavamzadeh A, Nikbin B. Aging of mesenchymal stem cell in vitro. BMC Cell Biol. 2006;7:14. https:\/\/doi.org\/10.1186\/1471-2121-7-14.","journal-title":"BMC Cell Biol"},{"key":"1520_CR330","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s10561-014-9420-6","volume":"15","author":"G Chen","year":"2014","unstructured":"Chen G, Yue A, Ruan Z, Yin Y, Wang R, Ren Y, et al. Monitoring the biology stability of human umbilical cord-derived mesenchymal stem cells during long-term culture in serum-free medium. Cell Tissue Bank. 2014;15:513\u201321. https:\/\/doi.org\/10.1007\/s10561-014-9420-6.","journal-title":"Cell Tissue Bank"},{"key":"1520_CR331","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.3892\/mmr.2012.1039","volume":"6","author":"X-Y Li","year":"2012","unstructured":"Li X-Y, Ding J, Zheng Z-H, Li X-Y, Wu Z-B, Zhu P. Long-term culture in vitro impairs the immunosuppressive activity of mesenchymal stem cells on T cells. Mol Med Rep. 2012;6:1183\u20139. https:\/\/doi.org\/10.3892\/mmr.2012.1039.","journal-title":"Mol Med Rep"},{"key":"1520_CR332","doi-asserted-by":"publisher","first-page":"5331","DOI":"10.1158\/0008-5472.CAN-08-4630","volume":"69","author":"GV R\u00f8sland","year":"2009","unstructured":"R\u00f8sland GV, Svendsen A, Torsvik A, Sobala E, McCormack E, Immervoll H, et al. Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation. Cancer Res. 2009;69:5331\u20139. https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-4630.","journal-title":"Cancer Res"},{"key":"1520_CR333","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13092480","volume":"13","author":"Md Carmona-Luque","year":"2024","unstructured":"Carmona-Luque Md, Ballesteros-Ribelles A, Mill\u00e1n-L\u00f3pez A, Blanco A, Nogueras S, Herrera C. The effect of cell culture passage on the efficacy of mesenchymal stromal cells as a cell therapy treatment. J Clin Med. 2024;13:2480. https:\/\/doi.org\/10.3390\/jcm13092480.","journal-title":"J Clin Med"},{"key":"1520_CR334","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1186\/s13287-024-04109-0","volume":"15","author":"X Bi","year":"2024","unstructured":"Bi X, Ma B, Liu W, Gao W-Q, Ye J, Rao H. Transcriptome-aligned metabolic profiling by SERSome reflects biological changes following mesenchymal stem cells expansion. Stem Cell Res Ther. 2024;15:467. https:\/\/doi.org\/10.1186\/s13287-024-04109-0.","journal-title":"Stem Cell Res Ther"},{"key":"1520_CR335","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02474","author":"A Andrzejewska","year":"2019","unstructured":"Andrzejewska A, Catar R, Schoon J, Qazi TH, Sass FA, Jacobi D, et al. Multi-parameter analysis of biobanked human bone marrow stromal cells shows little influence for donor age and mild comorbidities on phenotypic and functional properties. Front Immunol. 2019. https:\/\/doi.org\/10.3389\/fimmu.2019.02474.","journal-title":"Front Immunol"},{"key":"1520_CR336","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.stemcr.2014.05.003","volume":"3","author":"R Chinnadurai","year":"2014","unstructured":"Chinnadurai R, Garcia MA, Sakurai Y, Lam WA, Kirk AD, Galipeau J, et al. Actin cytoskeletal disruption following cryopreservation alters the biodistribution of human mesenchymal stromal cells in vivo. Stem Cell Reports. 2014;3:60\u201372. https:\/\/doi.org\/10.1016\/j.stemcr.2014.05.003.","journal-title":"Stem Cell Reports"},{"key":"1520_CR337","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3109\/14653249.2011.623691","volume":"14","author":"M Fran\u00e7ois","year":"2012","unstructured":"Fran\u00e7ois M, Copland IB, Yuan S, Romieu-Mourez R, Waller EK, Galipeau J. Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-\u03b3 licensing. Cytotherapy. 2012;14:147\u201352. https:\/\/doi.org\/10.3109\/14653249.2011.623691.","journal-title":"Cytotherapy"},{"key":"1520_CR338","doi-asserted-by":"publisher","first-page":"615","DOI":"10.5966\/sctm.2014-0268","volume":"4","author":"FF Cruz","year":"2015","unstructured":"Cruz FF, Borg ZD, Goodwin M, Sokocevic D, Wagner D, McKenna DH, et al. Freshly thawed and continuously cultured human bone marrow-derived mesenchymal stromal cells comparably ameliorate allergic airways inflammation in immunocompetent mice. Stem Cells Transl Med. 2015;4:615\u201324. https:\/\/doi.org\/10.5966\/sctm.2014-0268.","journal-title":"Stem Cells Transl Med"},{"key":"1520_CR339","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.jcyt.2014.10.018","volume":"17","author":"J Luetzkendorf","year":"2015","unstructured":"Luetzkendorf J, Nerger K, Hering J, Moegel A, Hoffmann K, Hoefers C, et al. Cryopreservation does not alter main characteristics of Good Manufacturing Process\u2013grade human multipotent mesenchymal stromal cells including immunomodulating potential and lack of malignant transformation. Cytotherapy. 2015;17:186\u201398. https:\/\/doi.org\/10.1016\/j.jcyt.2014.10.018.","journal-title":"Cytotherapy"},{"key":"1520_CR340","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-019-2038-5","volume":"17","author":"B Antebi","year":"2019","unstructured":"Antebi B, Asher AM, Rodriguez LA, Moore RK, Mohammadipoor A, Cancio LC. Cryopreserved mesenchymal stem cells regain functional potency following a 24-h acclimation period. J Transl Med. 2019;17:297. https:\/\/doi.org\/10.1186\/s12967-019-2038-5.","journal-title":"J Transl Med"},{"key":"1520_CR341","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-024-03954-3","volume":"15","author":"J Wang","year":"2024","unstructured":"Wang J, Li R. Effects, methods and limits of the cryopreservation on mesenchymal stem cells. Stem Cell Res Ther. 2024;15:337. https:\/\/doi.org\/10.1186\/s13287-024-03954-3.","journal-title":"Stem Cell Res Ther"},{"key":"1520_CR342","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics11110552","volume":"11","author":"JA Guadix","year":"2019","unstructured":"Guadix JA, L\u00f3pez-Beas J, Clares B, Soriano-Ruiz JL, Zugaza JL, G\u00e1lvez-Mart\u00edn P. Principal criteria for evaluating the quality, safety and efficacy of hMSC-based products in clinical practice: current approaches and challenges. Pharmaceutics. 2019;11:552. https:\/\/doi.org\/10.3390\/pharmaceutics11110552.","journal-title":"Pharmaceutics"},{"key":"1520_CR343","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.nucmedbio.2011.03.008","volume":"38","author":"A Gholamrezanezhad","year":"2011","unstructured":"Gholamrezanezhad A, Mirpour S, Bagheri M, Mohamadnejad M, Alimoghaddam K, Abdolahzadeh L, et al. In vivo tracking of 111In-oxine labeled mesenchymal stem cells following infusion in patients with advanced cirrhosis. Nucl Med Biol. 2011;38:961\u20137. https:\/\/doi.org\/10.1016\/j.nucmedbio.2011.03.008.","journal-title":"Nucl Med Biol"},{"key":"1520_CR344","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.3748\/wjg.v18.i10.1048","volume":"18","author":"W Zhao","year":"2012","unstructured":"Zhao W, Li J-J, Cao D-Y, Li X, Zhang L-Y, He Y, et al. Intravenous injection of mesenchymal stem cells is effective in treating liver fibrosis. World J Gastroenterol. 2012;18:1048\u201358. https:\/\/doi.org\/10.3748\/wjg.v18.i10.1048.","journal-title":"World J Gastroenterol"},{"key":"1520_CR345","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1053\/j.gastro.2008.03.015","volume":"134","author":"TK Kuo","year":"2008","unstructured":"Kuo TK, Hung S, Chuang C, Chen C, Shih YV, Fang SY, et al. Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells. Gastroenterology. 2008;134:2111-2121.e3. https:\/\/doi.org\/10.1053\/j.gastro.2008.03.015.","journal-title":"Gastroenterology"},{"key":"1520_CR346","doi-asserted-by":"publisher","first-page":"447","DOI":"10.3967\/bes2024.180","volume":"38","author":"JJ Ren","year":"2025","unstructured":"Ren JJ, Li ZX, Shi XR, Lyu TT, Li XN, Ge M, et al. Exploring the efficacy of BMSC transplantation via various pathways for treating cholestatic liver fibrosis in mice. Biomed Environ Sci: BES. 2025;38:447\u201358. https:\/\/doi.org\/10.3967\/bes2024.180.","journal-title":"Biomed Environ Sci: BES"},{"key":"1520_CR347","doi-asserted-by":"publisher","first-page":"382","DOI":"10.14218\/JCTH.2021.00580","volume":"11","author":"F-Y Liu","year":"2023","unstructured":"Liu F-Y, Shi M, Li X, Yuan H-J, Tian X-M, Xia Y-M, et al. MRI\/PAI dual-modal imaging-guided precise tracking of bone marrow-derived mesenchymal stem cells labeled with nanoparticles for treating liver cirrhosis. J Clin Transl Hepatol. 2023;11:382\u201392. https:\/\/doi.org\/10.14218\/JCTH.2021.00580.","journal-title":"J Clin Transl Hepatol"},{"key":"1520_CR348","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/s13287-023-03494-2","volume":"14","author":"H Wang","year":"2023","unstructured":"Wang H, Yao W, Wang Y, Dong H, Dong T, Zhou W, et al. Meta-analysis on last ten years of clinical injection of bone marrow-derived and umbilical cord MSC to reverse cirrhosis or rescue patients with acute-on-chronic liver failure. Stem Cell Res Ther. 2023;14:267. https:\/\/doi.org\/10.1186\/s13287-023-03494-2.","journal-title":"Stem Cell Res Ther"},{"key":"1520_CR349","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1186\/s13287-024-03916-9","volume":"15","author":"M Brizio","year":"2024","unstructured":"Brizio M, Mancini M, Lora M, Joy S, Zhu S, Brilland B, et al. Cytokine priming enhances the antifibrotic effects of human adipose derived mesenchymal stromal cells conditioned medium. Stem Cell Res Ther. 2024;15:329. https:\/\/doi.org\/10.1186\/s13287-024-03916-9.","journal-title":"Stem Cell Res Ther"},{"key":"1520_CR350","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1186\/s12967-023-04732-0","volume":"21","author":"Y Xie","year":"2023","unstructured":"Xie Y, Yao J, Yan M, Lin Y, Wei J, Wang H, et al. Pretreatment of UC-MSCs with IFN-\u03b12 improves treatment of liver fibrosis by recruiting neutrophils. J Transl Med. 2023;21:832. https:\/\/doi.org\/10.1186\/s12967-023-04732-0.","journal-title":"J Transl Med"},{"key":"1520_CR351","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-023-03342-3","author":"X Luan","year":"2023","unstructured":"Luan X, Chen P, Li Y, Yuan X, Miao L, Zhang P, et al. TNF-\u03b1\/IL-1\u03b2-licensed hADSCs alleviate cholestatic liver injury and fibrosis in mice via COX-2\/PGE2 pathway. Stem Cell Res Ther. 2023. https:\/\/doi.org\/10.1186\/s13287-023-03342-3.","journal-title":"Stem Cell Res Ther"},{"key":"1520_CR352","doi-asserted-by":"publisher","first-page":"207","DOI":"10.7508\/ibj.2016.04.004","volume":"20","author":"K Mortezaee","year":"2016","unstructured":"Mortezaee K, Pasbakhsh P, Ragerdi Kashani I, Sabbaghziarani F, Omidi A, Zendedel A, et al. Melatonin pretreatment enhances the homing of bone marrow-derived mesenchymal stem cells following transplantation in a rat model of liver fibrosis. Iran Biomed J. 2016;20:207\u201316. https:\/\/doi.org\/10.7508\/ibj.2016.04.004.","journal-title":"Iran Biomed J"},{"key":"1520_CR353","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.4252\/wjsc.v13.i10.1580","volume":"13","author":"A Fatima","year":"2021","unstructured":"Fatima A, Malick TS, Khan I, Ishaque A, Salim A. Effect of glycyrrhizic acid and 18\u03b2-glycyrrhetinic acid on the differentiation of human umbilical cord-mesenchymal stem cells into hepatocytes. World J Stem Cells. 2021;13:1580\u201394. https:\/\/doi.org\/10.4252\/wjsc.v13.i10.1580.","journal-title":"World J Stem Cells"},{"key":"1520_CR354","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.120969","volume":"308","author":"T-S Chen","year":"2022","unstructured":"Chen T-S, Lai Y-A, Lai Y-J, Chien C-T. Adipose stem cells preincubated with theanine exert liver regeneration through increase of stem cell paracrine VEGF and suppression of ROS, pyroptosis as well as autophagy markers in liver damage induced by N-nitrosodiethylamine. Life Sci. 2022;308:120969. https:\/\/doi.org\/10.1016\/j.lfs.2022.120969.","journal-title":"Life Sci"},{"key":"1520_CR355","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-023-01546-3","author":"C Jiang","year":"2023","unstructured":"Jiang C, Chen H, Kang Y, He X, Huang J, Lu T, et al. Administration of AG490 decreases the senescence of umbilical cord-mesenchymal stem cells and promotes the cytotherapeutic effect in liver fibrosis. Cell Death Discov. 2023. https:\/\/doi.org\/10.1038\/s41420-023-01546-3.","journal-title":"Cell Death Discov"},{"key":"1520_CR356","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.reth.2019.08.005","volume":"11","author":"Y Kojima","year":"2019","unstructured":"Kojima Y, Tsuchiya A, Ogawa M, Nojiri S, Takeuchi S, Watanabe T, et al. Mesenchymal stem cells cultured under hypoxic conditions had a greater therapeutic effect on mice with liver cirrhosis compared to those cultured under normal oxygen conditions. Regen Ther. 2019;11:269\u201381. https:\/\/doi.org\/10.1016\/j.reth.2019.08.005.","journal-title":"Regen Ther"},{"key":"1520_CR357","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1080\/19768354.2020.1823473","volume":"24","author":"I Ullah","year":"2020","unstructured":"Ullah I, Seo K, Wi H, Kim Y, Lee S, Ock SA. Induction of the differentiation of porcine bone marrow mesenchymal stem cells into premature hepatocyte-like cells in an indirect coculture system with primary hepatocytes. Anim Cells Syst. 2020;24:289\u201398. https:\/\/doi.org\/10.1080\/19768354.2020.1823473.","journal-title":"Anim Cells Syst"},{"key":"1520_CR358","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1186\/s13287-024-03934-7","volume":"15","author":"S Li","year":"2024","unstructured":"Li S, Fu X, Wang J, Yang H, Wang D, Dong X, et al. Therapeutic efficacy and in vivo distribution of human umbilical cord-derived mesenchymal stem cell spheroids transplanted via B-ultrasound-guided percutaneous portal vein puncture in rhesus monkey models of liver fibrosis. Stem Cell Res Ther. 2024;15:315. https:\/\/doi.org\/10.1186\/s13287-024-03934-7.","journal-title":"Stem Cell Res Ther"},{"key":"1520_CR359","doi-asserted-by":"publisher","first-page":"299","DOI":"10.7150\/ntno.81019","volume":"7","author":"GA-E Tawfeek","year":"2023","unstructured":"Tawfeek GA-E, Kasem HA, Elshoala SE. Curcumin nanofiber PCL\/PLGA\/collagen enhanced the therapeutic efficacy of mesenchymal stem cells against liver fibrosis in animal model and prevented its recurrence. Nanotheranostics. 2023;7:299\u2013315. https:\/\/doi.org\/10.7150\/ntno.81019.","journal-title":"Nanotheranostics"},{"key":"1520_CR360","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13008-023-00104-8","volume":"19","author":"H Xu","year":"2024","unstructured":"Xu H, Huang Y, Zhang F, Shi W, Cheng Y, Yang K, et al. Ultrasonic microbubbles promote mesenchymal stem cell homing to the fibrotic liver via upregulation of CXCR4 expression. Cell Div. 2024;19:7. https:\/\/doi.org\/10.1186\/s13008-023-00104-8.","journal-title":"Cell Div"},{"key":"1520_CR361","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-025-04351-0","volume":"16","author":"Y Fang","year":"2025","unstructured":"Fang Y, Chen L, Yuan Y, Zhou S, Fu J, Zhang Q, et al. Human menstrual blood-derived stem cells secreted ECM1 directly interacts with LRP1\u03b1 to ameliorate hepatic fibrosis through FoxO1 and mTOR signaling pathway. Stem Cell Res Ther. 2025;16:230. https:\/\/doi.org\/10.1186\/s13287-025-04351-0.","journal-title":"Stem Cell Res Ther"},{"key":"1520_CR362","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2024.0741","author":"JY Kim","year":"2025","unstructured":"Kim JY, Park H, Park SY, Kim SH, Lim JY, Lee KS, et al. Modulation of PRL-1 within placental MSCs instigates the transition between EMT and MET subsequent to hepatic fibrosis. Clin Mol Hepatol. 2025. https:\/\/doi.org\/10.3350\/cmh.2024.0741.","journal-title":"Clin Mol Hepatol"},{"key":"1520_CR363","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1089\/ars.2023.0390","volume":"41","author":"S Chawla","year":"2024","unstructured":"Chawla S, Choudhury S, Das A. Bioengineered MSCGFPCxcr2-Mmp13 transplantation alleviates hepatic fibrosis by regulating mammalian target of rapamycin signaling. Antioxid Redox Signal. 2024;41:110\u201337. https:\/\/doi.org\/10.1089\/ars.2023.0390.","journal-title":"Antioxid Redox Signal"},{"key":"1520_CR364","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25137235","volume":"25","author":"L He","year":"2024","unstructured":"He L, Xu J, Huang P, Bai Y, Chen H, Xu X, et al. Mir-9-5p and mir-221-3p promote human mesenchymal stem cells to alleviate carbon tetrachloride-induced liver injury by enhancing human mesenchymal stem cell engraftment and inhibiting hepatic stellate cell activation. Int J Mol Sci. 2024;25:7235. https:\/\/doi.org\/10.3390\/ijms25137235.","journal-title":"Int J Mol Sci"},{"key":"1520_CR365","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1080\/15384101.2024.2345477","volume":"23","author":"T Damba","year":"2024","unstructured":"Damba T, Zhang M, Serna Salas SA, Wu Z, Van Goor H, Arenas AF, et al. Inhibition of endogenous hydrogen sulfide production reduces activation of hepatic stellate cells via the induction of cellular senescence. Cell Cycle. 2024;23:629\u201344. https:\/\/doi.org\/10.1080\/15384101.2024.2345477.","journal-title":"Cell Cycle"},{"key":"1520_CR366","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-024-03486-w","volume":"22","author":"Y Liang","year":"2024","unstructured":"Liang Y, Luo S, Bell S, Mo JMY, He B, Zhou Y, et al. Do iron homeostasis biomarkers mediate the associations of liability to type 2 diabetes and glycemic traits in liver steatosis and cirrhosis: a two-step Mendelian randomization study. BMC Med. 2024;22:270. https:\/\/doi.org\/10.1186\/s12916-024-03486-w.","journal-title":"BMC Med"},{"key":"1520_CR367","doi-asserted-by":"publisher","DOI":"10.3390\/gels11040250","volume":"11","author":"DKM Bolinas","year":"2025","unstructured":"Bolinas DKM, Barcena AJR, Mishra A, Bernardino MR, Lin V, Heralde FM, et al. Mesenchymal stem cells loaded in injectable alginate hydrogels promote liver growth and attenuate liver fibrosis in cirrhotic rats. Gels. 2025;11:250. https:\/\/doi.org\/10.3390\/gels11040250.","journal-title":"Gels"},{"key":"1520_CR368","doi-asserted-by":"publisher","first-page":"4201","DOI":"10.1039\/d5tb00275c","volume":"13","author":"W Li","year":"2025","unstructured":"Li W, Shi X, Zhang D, Hu J, Zhao S, Ye S, et al. Adipose derived mesenchymal stem cell-seeded regenerated silk fibroin scaffolds reverse liver fibrosis in mice. J Mater Chem B. 2025;13:4201\u201313. https:\/\/doi.org\/10.1039\/d5tb00275c.","journal-title":"J Mater Chem B"},{"key":"1520_CR369","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2024.158313","volume":"503","author":"S Kim","year":"2025","unstructured":"Kim S, Lee DH, Park HW, Noh KM, Jangid AK, Park H, et al. Amphiphilic lipid conjugate-mediated surface engineering of placenta-derived mesenchymal stem cells for alleviating liver damage and fibrosis. Chem Eng J. 2025;503:158313. https:\/\/doi.org\/10.1016\/j.cej.2024.158313.","journal-title":"Chem Eng J"},{"key":"1520_CR370","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2024.100958","volume":"25","author":"Q Shi","year":"2024","unstructured":"Shi Q, Xia Y, Wu M, Pan Y, Wu S, Lin J, et al. Mi-BMSCs alleviate inflammation and fibrosis in CCl4-and TAA-induced liver cirrhosis by inhibiting TGF-\u03b2\/Smad signaling. Mater Today Bio. 2024;25:100958. https:\/\/doi.org\/10.1016\/j.mtbio.2024.100958.","journal-title":"Mater Today Bio"},{"key":"1520_CR371","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114451","volume":"161","author":"L Fan","year":"2023","unstructured":"Fan L, Wei A, Gao Z, Mu X. Current progress of mesenchymal stem cell membrane-camouflaged nanoparticles for targeted therapy. Biomed Pharmacother. 2023;161:114451. https:\/\/doi.org\/10.1016\/j.biopha.2023.114451.","journal-title":"Biomed Pharmacother"},{"key":"1520_CR372","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jconrel.2024.08.006","volume":"374","author":"Q Yao","year":"2024","unstructured":"Yao Q, Wang B, Yu J, Pan Q, Yu Y, Feng X, et al. ROS-responsive nanoparticle delivery of obeticholic acid mitigate primary sclerosing cholangitis. J Control Release. 2024;374:112\u201326. https:\/\/doi.org\/10.1016\/j.jconrel.2024.08.006.","journal-title":"J Control Release"},{"key":"1520_CR373","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-03029-8","volume":"22","author":"Y Tian","year":"2024","unstructured":"Tian Y, Sun D, Liu N, Zhao J, Zhao T, Liu X, et al. Biomimetic mesenchymal stem cell membrane-coated nanoparticle delivery of MKP5 inhibits hepatic fibrosis through the IRE\/XBP1 pathway. J Nanobiotechnol. 2024;22:741. https:\/\/doi.org\/10.1186\/s12951-024-03029-8.","journal-title":"J Nanobiotechnol"},{"key":"1520_CR374","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1002\/stem.2573","volume":"35","author":"N Souidi","year":"2017","unstructured":"Souidi N, Stolk M, Rudeck J, Strunk D, Schallmoser K, Volk H-D, et al. Stromal cells act as guardians for endothelial progenitors by reducing their immunogenicity after co-transplantation. Stem Cells. 2017;35:1233\u201345. https:\/\/doi.org\/10.1002\/stem.2573.","journal-title":"Stem Cells"},{"key":"1520_CR375","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/395781","volume":"2014","author":"M Loibl","year":"2014","unstructured":"Loibl M, Binder A, Herrmann M, Duttenhoefer F, Richards RG, Nerlich M, et al. Direct cell-cell contact between mesenchymal stem cells and endothelial progenitor cells induces a pericyte-like phenotype in vitro. Biomed Res Int. 2014;2014:395781. https:\/\/doi.org\/10.1155\/2014\/395781.","journal-title":"Biomed Res Int"},{"key":"1520_CR376","doi-asserted-by":"publisher","first-page":"e0138846","DOI":"10.1371\/journal.pone.0138846","volume":"10","author":"E-S Lee","year":"2015","unstructured":"Lee E-S, Lim J-Y, Im K-I, Kim N, Nam Y-S, Jeon Y-W, et al. Adoptive transfer of treg cells combined with mesenchymal stem cells facilitates repopulation of endogenous treg cells in a murine acute GVHD model. PLoS ONE. 2015;10:e0138846. https:\/\/doi.org\/10.1371\/journal.pone.0138846.","journal-title":"PLoS ONE"},{"key":"1520_CR377","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25020348","volume":"25","author":"M Fathy","year":"2020","unstructured":"Fathy M, Okabe M, Saad Eldien HM, Yoshida T. AT-MSCs antifibrotic activity is improved by Eugenol through modulation of TGF-\u03b2\/Smad signaling pathway in rats. Molecules. 2020;25:348. https:\/\/doi.org\/10.3390\/molecules25020348.","journal-title":"Molecules"},{"key":"1520_CR378","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.reth.2021.07.002","volume":"18","author":"T Iwasawa","year":"2021","unstructured":"Iwasawa T, Nojiri S, Tsuchiya A, Takeuchi S, Watanabe T, Ogawa M, et al. Combination therapy of Juzentaihoto and mesenchymal stem cells attenuates liver damage and regresses fibrosis in mice. Regen Therapy. 2021;18:231\u201341. https:\/\/doi.org\/10.1016\/j.reth.2021.07.002.","journal-title":"Regen Therapy"},{"key":"1520_CR379","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.863797","author":"R Zhang","year":"2022","unstructured":"Zhang R, Li W, Jiang X, Cui X, You H, Tang Z, et al. Ferulic acid combined with bone marrow mesenchymal stem cells attenuates the activation of hepatic stellate cells and alleviates liver fibrosis. Front Pharmacol. 2022. https:\/\/doi.org\/10.3389\/fphar.2022.863797.","journal-title":"Front Pharmacol"},{"key":"1520_CR380","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.bbrc.2018.02.067","volume":"497","author":"YO Jang","year":"2018","unstructured":"Jang YO, Kim SH, Cho M-Y, Kim KS, Park K-S, Cha S-K, et al. Synergistic effects of simvastatin and bone marrow-derived mesenchymal stem cells on hepatic fibrosis. Biochem Biophys Res Commun. 2018;497:264\u201371. https:\/\/doi.org\/10.1016\/j.bbrc.2018.02.067.","journal-title":"Biochem Biophys Res Commun"},{"key":"1520_CR381","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173263","volume":"882","author":"S Mazhari","year":"2020","unstructured":"Mazhari S, Gitiara A, Baghaei K, Hatami B, Rad RE, Asadirad A, et al. Therapeutic potential of bone marrow-derived mesenchymal stem cells and imatinib in a rat model of liver fibrosis. Eur J Pharmacol. 2020;882:173263. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173263.","journal-title":"Eur J Pharmacol"},{"key":"1520_CR382","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.2174\/011574888X279940231206100902","volume":"19","author":"V Slautin","year":"2024","unstructured":"Slautin V, Konyshev K, Gavrilov I, Beresneva O, Maklakova I, Grebnev D. Fucoxanthin enhances the antifibrotic potential of placenta-derived mesenchymal stem cells in a CCl4-induced mouse model of liver. CSCR. 2024;19:1484\u201396. https:\/\/doi.org\/10.2174\/011574888X279940231206100902.","journal-title":"CSCR"},{"key":"1520_CR383","doi-asserted-by":"publisher","first-page":"3766","DOI":"10.3748\/wjg.v30.i32.3766","volume":"30","author":"Y Xu","year":"2024","unstructured":"Xu Y, Wang X-S, Zhou X-L, Lu W-M, Tang X-K, Jin Y, et al. Mesenchymal stem cell therapy for liver fibrosis need \u201cpartner\u201d: results based on a meta-analysis of preclinical studies. World J Gastroenterol. 2024;30:3766\u201382. https:\/\/doi.org\/10.3748\/wjg.v30.i32.3766.","journal-title":"World J Gastroenterol"},{"key":"1520_CR384","doi-asserted-by":"publisher","DOI":"10.1002\/btm2.10735","volume":"10","author":"S Yu","year":"2025","unstructured":"Yu S, Wang Y, Shi Y, Yu S, Zhao B, Liao N, et al. Reduced glutathione enhances adipose tissue\u2010derived mesenchymal stem cell engraftment efficiency for liver fibrosis by targeting TGF\u03b21 \/ SMAD3 \/ NOX4 pathway. Bioeng Transla Med. 2025;10:e10735. https:\/\/doi.org\/10.1002\/btm2.10735.","journal-title":"Bioeng Transla Med"},{"key":"1520_CR385","first-page":"131","volume":"19","author":"M Vosough","year":"2016","unstructured":"Vosough M, Moossavi S, Mardpour S, Akhlaghpoor S, Azimian V, Jarughi N, et al. Repeated intraportal injection of mesenchymal stem cells in combination with pioglitazone in patients with compensated cirrhosis: a clinical report of two cases. Arch Iran Med. 2016;19:131\u20136.","journal-title":"Arch Iran Med"},{"key":"1520_CR386","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1080\/15384101.2025.2492423","volume":"23","author":"F Varzideh","year":"2024","unstructured":"Varzideh F, Kansakar U, Wilson S, Jankauskas SS, Santulli G. The SGLT2 inhibitor canagliflozin attenuates mitochondrial oxidative stress and alterations of calcium handling induced by high glucose in human cardiac fibroblasts. Cell Cycle. 2024;23:923\u201330. https:\/\/doi.org\/10.1080\/15384101.2025.2492423.","journal-title":"Cell Cycle"},{"key":"1520_CR387","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107526","volume":"210","author":"X Liu","year":"2024","unstructured":"Liu X, Cai Y, Zhang Y, Zhang H, Tian S, Gong Y, et al. Artesunate: a potential drug for the prevention and treatment from hepatitis to hepatocellular carcinoma. Pharmacol Res. 2024;210:107526. https:\/\/doi.org\/10.1016\/j.phrs.2024.107526.","journal-title":"Pharmacol Res"},{"key":"1520_CR388","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107375","volume":"208","author":"N Sharma","year":"2024","unstructured":"Sharma N, Singh L, Sharma A, Kumar A, Mahajan D. NAFLD-associated hepatocellular carcinoma (HCC) \u2013 a compelling case for repositioning of existing mTORc1 inhibitors. Pharmacol Res. 2024;208:107375. https:\/\/doi.org\/10.1016\/j.phrs.2024.107375.","journal-title":"Pharmacol Res"},{"key":"1520_CR389","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12410","volume":"13","author":"Y Gao","year":"2024","unstructured":"Gao Y, Mi N, Wu W, Zhao Y, Fan F, Liao W, et al. Transfer of inflammatory mitochondria via extracellular vesicles from M1 macrophages induces ferroptosis of pancreatic beta cells in acute pancreatitis. J Extracell Vesicle. 2024;13:e12410. https:\/\/doi.org\/10.1002\/jev2.12410.","journal-title":"J Extracell Vesicle"},{"key":"1520_CR390","doi-asserted-by":"publisher","DOI":"10.1155\/sci\/4639115","volume":"2025","author":"R Hu","year":"2025","unstructured":"Hu R, Zhao J, Cheng Y, Su W, Ren R, Zhang H, et al. Exogenous mitochondrial pretreatment enhances the therapeutic effect of UC-MSCs on NAFLD in type 2 diabetic mice by mediating mitochondrial transfer. Stem Cells Int. 2025;2025:4639115. https:\/\/doi.org\/10.1155\/sci\/4639115.","journal-title":"Stem Cells Int"},{"key":"1520_CR391","doi-asserted-by":"publisher","DOI":"10.1111\/jpi.12747","volume":"71","author":"MG Nasoni","year":"2021","unstructured":"Nasoni MG, Carloni S, Canonico B, Burattini S, Cesarini E, Papa S, et al. Melatonin reshapes the mitochondrial network and promotes intercellular mitochondrial transfer via tunneling nanotubes after ischemic-like injury in hippocampal HT22 cells. J Pineal Res. 2021;71:e12747. https:\/\/doi.org\/10.1111\/jpi.12747.","journal-title":"J Pineal Res"},{"key":"1520_CR392","doi-asserted-by":"publisher","first-page":"687","DOI":"10.3390\/molecules23030687","volume":"23","author":"V Babenko","year":"2018","unstructured":"Babenko V, Silachev D, Popkov V, Zorova L, Pevzner I, Plotnikov E, et al. Miro1 enhances mitochondria transfer from multipotent mesenchymal stem cells (MMSC) to neural cells and improves the efficacy of cell recovery. Molecules. 2018;23:687. https:\/\/doi.org\/10.3390\/molecules23030687.","journal-title":"Molecules"},{"key":"1520_CR393","doi-asserted-by":"publisher","DOI":"10.1002\/embj.201386030","author":"T Ahmad","year":"2014","unstructured":"Ahmad T, Mukherjee S, Pattnaik B, Kumar M, Singh S, Kumar M, et al. Miro1 regulates intercellular mitochondrial transport & enhances mesenchymal stem cell rescue efficacy. EMBO J. 2014. https:\/\/doi.org\/10.1002\/embj.201386030.","journal-title":"EMBO J"},{"key":"1520_CR394","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.stemcr.2018.09.012","volume":"11","author":"Y Yao","year":"2018","unstructured":"Yao Y, Fan X-L, Jiang D, Zhang Y, Li X, Xu Z-B, et al. Connexin 43-mediated mitochondrial transfer of iPSC-MSCs alleviates asthma inflammation. Stem Cell Reports. 2018;11:1120\u201335. https:\/\/doi.org\/10.1016\/j.stemcr.2018.09.012.","journal-title":"Stem Cell Reports"},{"key":"1520_CR395","doi-asserted-by":"publisher","first-page":"E968","DOI":"10.1073\/pnas.1521230113","volume":"113","author":"J Kowal","year":"2016","unstructured":"Kowal J, Arras G, Colombo M, Jouve M, Morath JP, Primdal-Bengtson B, et al. Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes. Proc Natl Acad Sci U S A. 2016;113:E968\u201377. https:\/\/doi.org\/10.1073\/pnas.1521230113.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1520_CR396","doi-asserted-by":"publisher","DOI":"10.1186\/s40824-023-00371-0","volume":"27","author":"N Prakash","year":"2023","unstructured":"Prakash N, Kim J, Jeon J, Kim S, Arai Y, Bello AB, et al. Progress and emerging techniques for biomaterial-based derivation of mesenchymal stem cells (MSCs) from pluripotent stem cells (PSCs). Biomater Res. 2023;27:31. https:\/\/doi.org\/10.1186\/s40824-023-00371-0.","journal-title":"Biomater Res"},{"key":"1520_CR397","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.654","volume":"5","author":"L Chen","year":"2024","unstructured":"Chen L, Huang Y, Zhang N, Qu J, Fang Y, Fu J, et al. Single-cell RNA sequencing reveals reduced intercellular adhesion molecule crosstalk between activated hepatic stellate cells and neutrophils alleviating liver fibrosis in hepatitis B virus transgenic mice post menstrual blood-derived mesenchymal stem cell transplantation. MedComm. 2024;5:e654. https:\/\/doi.org\/10.1002\/mco2.654.","journal-title":"MedComm"},{"key":"1520_CR398","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-024-03817-x","volume":"15","author":"D Hu","year":"2024","unstructured":"Hu D, Lai J, Chen Q, Bai L. New advances of NG2-expressing cell subset in marrow mesenchymal stem cells as novel therapeutic tools for liver fibrosis\/cirrhosis. Stem Cell Res Ther. 2024;15:199. https:\/\/doi.org\/10.1186\/s13287-024-03817-x.","journal-title":"Stem Cell Res Ther"},{"key":"1520_CR399","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1126\/sciadv.adi2387","volume":"9","author":"RH Lee","year":"2023","unstructured":"Lee RH, Boregowda SV, Shigemoto-Kuroda T, Bae E, Haga CL, Abbery CA, et al. TWIST1 and TSG6 are coordinately regulated and function as potency biomarkers in human MSCs. Sci Adv. 2023;9:2387. https:\/\/doi.org\/10.1126\/sciadv.adi2387.","journal-title":"Sci Adv"},{"key":"1520_CR400","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-024-03618-2","volume":"22","author":"M Liu","year":"2024","unstructured":"Liu M, Ye Z, Zhang Y, He P, Zhou C, Yang S, et al. Accelerometer-derived moderate-to-vigorous physical activity and incident nonalcoholic fatty liver disease. BMC Med. 2024;22:398. https:\/\/doi.org\/10.1186\/s12916-024-03618-2.","journal-title":"BMC Med"},{"key":"1520_CR401","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.cmet.2024.12.005","volume":"37","author":"Y Liu","year":"2025","unstructured":"Liu Y, Zhou R, Guo Y, Hu B, Xie L, An Y, et al. Muscle-derived small extracellular vesicles induce liver fibrosis during overtraining. Cell Metab. 2025;37:824-841.e8. https:\/\/doi.org\/10.1016\/j.cmet.2024.12.005.","journal-title":"Cell Metab"},{"key":"1520_CR402","doi-asserted-by":"publisher","unstructured":"Burke BI, McCarthy JJ, Ismaeel A. From gains to liver pain: when exercise training goes too far. OAE Publ Inc.; 2025. https:\/\/doi.org\/10.20517\/evcna.2025.36","DOI":"10.20517\/evcna.2025.36"},{"key":"1520_CR403","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1186\/s12916-024-03744-x","volume":"22","author":"I Oma\u00f1a-Guzm\u00e1n","year":"2024","unstructured":"Oma\u00f1a-Guzm\u00e1n I, Rosas-Diaz M, Mart\u00ednez-L\u00f3pez YE, Perez-Navarro LM, Diaz-Badillo A, Alanis A, et al. Strategic interventions in clinical randomized trials for metabolic dysfunction-associated steatotic liver disease (MASLD) and obesity in the pediatric population: a systematic review with meta-analysis and bibliometric analysis. BMC Med. 2024;22:548. https:\/\/doi.org\/10.1186\/s12916-024-03744-x.","journal-title":"BMC Med"},{"key":"1520_CR404","doi-asserted-by":"publisher","first-page":"1420088","DOI":"10.3389\/fendo.2024.1420088","volume":"15","author":"N Huang","year":"2024","unstructured":"Huang N, Su X, Yu T, Wu X, Lu B, Sun W, et al. Serum 25-hydroxy vitamin D level is associated with elastography-detected liver fibrosis in patients with type 2 diabetes mellitus in China. Front Endocrinol. 2024;15:1420088. https:\/\/doi.org\/10.3389\/fendo.2024.1420088.","journal-title":"Front Endocrinol"},{"key":"1520_CR405","doi-asserted-by":"publisher","first-page":"2808","DOI":"10.1097\/CM9.0000000000003332","volume":"137","author":"L Zhang","year":"2024","unstructured":"Zhang L, Deng Y, Bai X, Wei X, Ren Y, Chen S, et al. Cell therapy for end-stage liver disease: current state and clinical challenge. Chin Med J (Engl). 2024;137:2808\u201320. https:\/\/doi.org\/10.1097\/CM9.0000000000003332.","journal-title":"Chin Med J (Engl)"},{"key":"1520_CR406","doi-asserted-by":"publisher","DOI":"10.1093\/eurjpc\/zwae336","author":"L He","year":"2024","unstructured":"He L, Tiemuerniyazi X, Yang Z, Huang S, Chen L, Nan Y, et al. The association between non-alcoholic liver fatty disease and coronary artery calcification: a two-sample Mendelian randomization study. Pubmed. 2024. https:\/\/doi.org\/10.1093\/eurjpc\/zwae336.","journal-title":"Pubmed."},{"key":"1520_CR407","doi-asserted-by":"publisher","DOI":"10.1093\/eurjpc\/zwae388","author":"C Gurevitz","year":"2024","unstructured":"Gurevitz C, Rosenson RS. Metabolic dysfunction\u2013associated steatotic liver disease, hypertriglyceridaemia, and cardiovascular risk. Pubmed. 2024. https:\/\/doi.org\/10.1093\/eurjpc\/zwae388.","journal-title":"Pubmed."},{"key":"1520_CR408","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-024-02408-7","volume":"23","author":"EJ Cho","year":"2024","unstructured":"Cho EJ, Chung GE, Yoo J-J, Cho Y, Lee KN, Shin DW, et al. Association of nonalcoholic fatty liver disease with new-onset atrial fibrillation stratified by age groups. Cardiovasc Diabetol. 2024;23:340. https:\/\/doi.org\/10.1186\/s12933-024-02408-7.","journal-title":"Cardiovasc Diabetol"},{"key":"1520_CR409","doi-asserted-by":"publisher","first-page":"1056562","DOI":"10.3389\/fendo.2022.1056562","volume":"13","author":"C-H Lee","year":"2023","unstructured":"Lee C-H, Lui DT-W, Li RH-W, Yuen MM-A, Fong CH-Y, Leung AP-W, et al. Sequential algorithm to stratify liver fibrosis risk in overweight\/obese metabolic dysfunction-associated fatty liver disease. Front Endocrinol. 2023;13:1056562. https:\/\/doi.org\/10.3389\/fendo.2022.1056562.","journal-title":"Front Endocrinol"},{"key":"1520_CR410","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-024-03502-z","volume":"22","author":"L Yang","year":"2024","unstructured":"Yang L, Zhang Y, Hong X, Zhang K, Liu B, Zhang P, et al. Serum dithiothreitol-oxidizing capacity (DOC) is a promising biomarker for excluding significant liver fibrosis: a proof-of-concept study. BMC Med. 2024;22:278. https:\/\/doi.org\/10.1186\/s12916-024-03502-z.","journal-title":"BMC Med"}],"container-title":["Cell &amp; Bioscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13578-025-01520-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13578-025-01520-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13578-025-01520-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T14:58:36Z","timestamp":1769785116000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13578-025-01520-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,30]]},"references-count":410,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1520"],"URL":"https:\/\/doi.org\/10.1186\/s13578-025-01520-9","relation":{},"ISSN":["2045-3701"],"issn-type":[{"value":"2045-3701","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,30]]},"assertion":[{"value":"23 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11"}}